cyclosporine has been researched along with Colitis Gravis in 441 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 105 (23.81) | 18.2507 |
2000's | 164 (37.19) | 29.6817 |
2010's | 133 (30.16) | 24.3611 |
2020's | 39 (8.84) | 2.80 |
Authors | Studies |
---|---|
Brcerevic, I; Brocic, T; El Jurdi, K; Gils, A; Jocic, T; Latinovic, O; Milenkovic, Z; Petrovic, S; Rubin, DT; Subotic, B; Tarabar, D; Traboulsi, C; Yvellez, O | 1 |
Juillerat, P; Laharie, D; Nachury, M; Pellet, G; Roblin, X; Veyrard, P | 1 |
Akobeng, AK; Gasiea, R; Gordon, M; Moran, GW; Pana, M; Sinopoulou, V | 1 |
Akyüz, F; Baran, B; Beşışık, F; Çavuş, B; Demir, K; Evirgen, S; Göktürk, S; İliaz, R; Karaca, Ç; Kaymakoğlu, S; Mutluay Soyer, Ö; Örmeci, A; Pınarbaşı, B | 1 |
Ashat, D; Barnes, EL; Herfarth, HH; Jain, A; Long, MD; Weaver, KN | 1 |
Adams, A; Ahuja, V; Ambrose, T; Brain, O; Chapman, TP; George, BD; Gupta, V; Kakkadasam Ramaswamy, P; Kedia, S; Kumar, S; McGregor, CG; Mohsen, W; Palmer, R; Satsangi, J; Subhaharan, D; Travis, SPL; Walsh, A | 1 |
Nakase, H | 1 |
Eronen, H; Helavirta, I; Huhtala, H; Ilus, T; Jussila, A; Oksanen, P | 1 |
Duan, Y; He, J; Hu, J; Hu, Z; Huang, J; Li, H; Li, Q; Liang, X; Liu, J; Sun, S; Wang, X; Zhao, T | 1 |
Chaparro, M; García, MJ; Gisbert, JP | 1 |
Alam, MF; Alrubaiy, L; Cohen, D; Groves, S; Hutchings, HA; Longo, M; Sebastain, S; Watkins, A; Williams, JG | 1 |
Huang, J; Li, G; Li, X; Si, L; Sun, M; Wang, D; Wu, Y; Xiao, C | 1 |
Chen, Y; Fang, P; Hao, S; He, H; Hu, H; Li, Y; Xiong, M; Xu, M; Yu, S | 1 |
Bao, L; Huang, J; Li, G; Li, Q; Si, L; Sun, M; Tan, S; Wang, D; Wu, Y | 1 |
Cotter, J; Cravo, M; de Deus, J; Dias, CC; Duque, G; Ferreira, F; Ferreira, PL; Magro, F; Ministro, P; Portela, F; Rosa, B | 1 |
Alrubaiy, L; Clement, C; Hutchings, HA; Rapport, F; Seagrove, AC; Williams, JG | 1 |
Bavaharan, B; Kawali, A; Mahendradas, P; Mohan, A; Sanjay, S; Shetty, B | 1 |
Okano, S; Sako, M; Takazoe, M; Yoshimura, N | 1 |
Axelrad, J; Chang, S; Hudesman, D; Rosen, MH; Rubin, DT | 1 |
Choi, S; Coburn, ES; Holubar, SD; Levy, LC | 1 |
Cordeiro, G; Dias, AM; Estevinho, MM; Magro, F | 1 |
Farkas, K; Molnar, T; Pigniczki, D; Resál, T; Rutka, M; Szántó, K | 1 |
Allez, M; Amiot, A; Beaugerie, L; Bouhnik, Y; Bourreille, A; Branche, J; Buisson, A; Carbonnel, F; Coffin, B; de Vos, M; Dewit, O; Esteve, M; Farkkila, M; Filippi, J; Fumery, M; Gisbert, JP; Laharie, D; Lopez-Sanroman, A; Marteau, P; Mary, JY; Moreau, J; Nahon, S; Peyrin-Biroulet, L; Ricart, E; Roblin, X; Savoye, G; van Assche, G; Vuitton, L; Zerbib, F | 1 |
Abdel-Mottaleb, MMA; Beduneau, A; Moulari, B; Pellequer, Y; Scarcello, E | 1 |
Gao, XJ; Hu, N; Li, S; Li, SL; Li, T; Wang, PP; Wei, B; Yan, R; Yan, ZX; Yang, Y; Zhang, ZJ | 1 |
Bor, R; Fábián, A; Farkas, K; Molnár, T; Szepes, Z | 1 |
Guo, R; He, J; Hu, Z; Jia, X; Li, B; Liu, J; Yang, Q | 1 |
Barberio, B; Black, CJ; Ford, AC; Savarino, EV | 1 |
Chiba, M; Ishii, H; Komatsu, M; Nakane, K; Obara, Y; Ohno, H; Tozawa, H; Tsuda, S; Tsuji, T | 1 |
Collin, P; Eronen, H; Huhtala, H; Ilus, T; Jussila, A; Oksanen, P | 1 |
Axelrad, JE; Freedberg, DE; Varma, S; Verma, A | 1 |
Feng, B; Huang, H; Li, M; Li, Z; Lin, J; Liu, Z; Lu, H; Sun, M; Wu, W; Xu, C; Zhang, X; Zuo, K | 1 |
Rosiou, K; Selinger, CP | 1 |
Byeon, JS; Hwang, SW; Myung, SJ; Oh, EH; Park, SH; Song, EM; Yang, DH; Yang, SK; Ye, BD | 1 |
Dai, C; Huang, YH; Jiang, M | 1 |
Cassata, N; Citrano, M; Graziano, F; Macaluso, FS; Orlando, A | 1 |
Dos Santos, CHM; Koga, GA | 1 |
Beltrán Niclós, B; Ladrón Abia, P; Minguez Sabater, A; Sáez González, E | 1 |
Al-Saifi, R; Atreya, R; August, A; Fraass, T; Knipfer, L; Lechner, K; Luban, J; Mott, S; Neurath, MF; Rath, T; Vieth, M; Weigmann, B; Winter, Z; Wirtz, S; Zimmermann, VS | 1 |
Chen, L; Fang, L; Feng, L; Liu, C; Liu, Z; Sun, X; Yang, Q | 1 |
Alrubaiy, L; Clement, C; Rapport, F; Seagrove, A; Williams, J | 1 |
Ananthakrishnan, AN | 1 |
Aso, A; Ihara, E; Ito, T; Iwasa, T; Nakamura, K | 1 |
Bar-Gil Shitrit, A; Barreiro de Acosta, M; Ben-Horin, S; Bossuyt, P; Boysen, T; Carbonnel, F; Chaparro, M; Christodoulou, DK; Dotan, I; Drobne, D; Eliakim, R; Ferrante, M; Ghalim, F; Har-Noy, O; Israeli, E; Katsanos, K; Kopylov, U; Levin, A; Maconi, G; Magro, F; Mantzaris, G; Muls, V; Papamichael, K; Peixoto, A; Portela, F; Rahier, JF; Raine, T; Roblin, X; Siegmund, B; Silva, M; Sonnenberg, E; Szilagyi, A; Thurm, T; Vermeire, S; Waterman, M; Yanai, H | 1 |
Aguas, M; Aguirresarobe, M; Bermejo, F; Calvet, X; Cañas-Ventura, A; Chaparro, M; De Castro, ML; Domènech, E; Esteve, M; Fernández, L; Fernández-Bañares, F; Garcia-Planella, E; García-Sánchez, V; García-Sepulcre, MF; Gento, E; Gomollón, F; Gutiérrez, A; Iglesias-Flores, E; Jiménez, CE; Mañosa, M; Merino, O; Mir, A; Montoro, MA; Muñoz, C; Muñoz, F; Ordás, I; Panés, J; Peñalva, M; Vera, M | 1 |
Courthion, H; Gabriel, D; Gurny, R; Möller, M; Mugnier, T; Rousseaux, C | 1 |
Bernstein, CN; Kornbluth, A | 1 |
Actis, GC; Pellicano, R | 1 |
Cohen, RD; Dalal, S; Hanan, I; Hanauer, SB; Patel, P; Pekow, J; Raffals, LH; Rubin, DT; Sakuraba, A; Yarur, A | 1 |
Choy, MC; De Cruz, P; Raval, M | 1 |
Wu, D; Yang, Z; Yao, L; Zhao, C | 1 |
Little, K | 1 |
Maj, J; Żychowska, M | 1 |
Ahuja, V; Jain, S; Limdi, JK | 1 |
Cohen, RD; Dalal, S; El Jurdi, K; Ollech, JE; Pekow, J; Rubin, DT; Sakuraba, A; Weisshof, R; Yvellez, OV | 1 |
Albuquerque, IC; Ambrogini Junior, O; Chebli, JMF; Damião, AOMC; Hossne, RS; Miszputen, SJ; Parente, JML; Teixeira, FV; Vieira, A; Vilela, EG | 1 |
Bressler, B; Moore, AC | 1 |
Bálint, A; Farkas, K; Molnár, T; Nagy, F; Szepes, Z; Szűcs, M; Wittmann, T | 2 |
Katsuno, T; Saito, K; Yokosuka, O | 2 |
Kane, SV; Yarur, A | 1 |
Akpinar, H; Bengi, G | 1 |
Lindsay, JO; Mehta, SJ; Silver, AR | 1 |
de Boer, NK; Seinen, ML; van Bodegraven, AA; van Kuilenburg, AB | 1 |
Calabrese, C; Gionchetti, P; Praticò, C; Rizzello, F | 1 |
Cooley, R; Croft, A; Doecke, J; Howlett, M; Radford-Smith, G; Walsh, A | 1 |
Arnott, ID; Driscoll, R; Lowe, D; Lynch, RW; Protheroe, A; Rhodes, JM | 1 |
de Boer, NK; Dewint, P; Hoentjen, F; Löwenberg, M | 1 |
Hamlin, PJ; Sprakes, MB | 1 |
Croft, A; Doecke, J; Radford-Smith, G; Walsh, A | 2 |
Gisbert, JP; Lopez-Sanroman, A | 1 |
Blonski, W; Buchner, AM; Lichtenstein, GR | 1 |
Fichera, A; Liao, C; Nelson, R; Pekow, J; Rubin, DT | 1 |
Barreiro-de Acosta, M; Gisbert, JP | 1 |
Arnott, ID; Lynch, RW | 1 |
Cabré, E; Calafat, M; Domènech, E; Mañosa, M | 1 |
Nitschmann, S; Zeitz, M | 1 |
Hamaguchi, T; Inoue, J; Kawauchi, S; Miki, I; Mizuno, S; Nakamura, T; Tanahashi, T | 1 |
Andreu, M; Calvet, X; Cañas-Ventura, A; Domènech, E; Esteve, M; Garcia-Planella, E; García-Sanchez, V; Gisbert, JP; Gomollón, F; Gutiérrez, A; Iborra, M; Marín-Jiménez, I; Márquez, L; Merino, O; Ricart, E; Rodriguez-Moranta, F; Vázquez-Romero, N; Vera, M | 1 |
Farkas, K; Molnár, T; Szepes, Z | 1 |
Alam, MF; Alrubaiy, L; Cheung, WY; Clement, C; Cohen, D; Grey, M; Hilton, M; Hutchings, H; Morgan, J; Rapport, F; Roberts, SE; Russell, D; Russell, I; Seagrove, AC; Thomas, L; Thorne, K; Watkins, A; Williams, JG | 1 |
Beglinger, C; Bojic, D; Frei, P; Jojic, N; Juillerat, P; Mottet, C; Mwinyi, J; Protic, M; Radojicic, Z; Rogler, G; Schoepfer, A; Seibold, F; Vavricka, S | 1 |
Gionchetti, P; Rizzello, F | 1 |
Cabré, E; Domènech, E; Garcia-Planella, E; Guardiola, J; Llaó, J; Lobatón, T; Mañosa, M; Naves, JE; Romero, C; Ruiz-Cerulla, A | 1 |
Cabré, E; Domènech, E; Garcia-Planella, E; Guardiola, J; Llaó, J; Mañosa, M; Marín, L; Naves, JE; Rodríguez-Alonso, L; Ruiz-Cerulla, A | 1 |
Atreya, I; Atreya, R; Daniel, C; Fischer, A; Hirschmann, S; Neumann, H; Neurath, M; Steiner, S; Waldner, M; Weigmann, B | 1 |
D'Haens, GR; Duijvis, NW; Fockens, P; Löwenberg, M; Ponsioen, C; van den Brink, GR | 1 |
Barreiro-de Acosta, M | 1 |
Cheon, JH; Hong, SP; Kim, DH; Kim, EH; Kim, TI; Kim, WH; Park, SJ | 1 |
Ando, T; Funasaka, K; Furukawa, K; Goto, H; Hirayama, Y; Ishiguro, K; Maeda, K; Maeda, O; Matsushita, M; Miyahara, R; Miyake, N; Morise, K; Nakamura, M; Ohmiya, N; Watanabe, O | 1 |
Choudhuri, G; Kochhar, R; Ramakrishna, BS | 1 |
Khosla, R; Kumar, NS; Makharia, GK | 1 |
Ahuja, V; Kochhar, R; Kumar, A | 1 |
Burger, D; Catuneanu, AM; Cesarini, M; Corte, C; Fernandopulle, N; Keshav, S; Travis, S; White, L | 1 |
Abdel-Galil, AG; El-Gowelli, HM; Ibrahim, ER; Saad, EI | 1 |
Barbruni, G; Caratto, E; Caratto, M; Fornaro, F; Fornaro, R; Giovinazzo, D; Salerno, A; Sticchi, C | 1 |
Eun, CS; Han, DS | 1 |
Futami, K; Hotokezaka, M; Ikeuchi, H; Kameyama, H; Kimura, H; Kurachi, K; Maeda, K; Nakao, S; Nezu, R; Otsuka, K; Ozawa, H; Takahashi, K; Tatsumi, K; Watadani, Y; Watanabe, K; Watanabe, T | 1 |
Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R | 1 |
De Cruz, P; Seah, D | 1 |
Bemelman, WA; Buskens, CJ; D'Haens, GR; Duijvis, NW; Löwenberg, M; Ponsioen, CI; Te Velde, AA; Ten Hove, AS; van den Brink, GR | 1 |
Akbari, A; Alrubaiy, L; Morrison-Rees, S; Roberts, SE; Samuel, DG; Thorne, K | 1 |
Colombel, JF; Leontiadis, GI; Marshall, JK; Muqtadir, Z; Narula, N; Reinisch, W; Williams, JG | 1 |
Cabré, E; Domènech, E; Garcia-Planella, E; Gordillo, J; Guardiola, J; Llaó, J; Maisterra, S; Mañosa, M; Naves, JE; Ruiz-Cerulla, A | 1 |
Belleannée, G; Capdepont, M; Chabrun, E; Fron, C; Laharie, D; Pierry, C; Poullenot, F; Subtil, C; Zerbib, F | 1 |
Aloi, M; Birimberg-Schwartz, L; Bronsky, J; Buderus, S; Fell, JM; Hojsak, I; Koletzko, S; Miele, E; Russell, RK; Shaoul, R; Turner, D; Veereman, G | 1 |
Andrews, JM; Chang, J; Chen, JH; Collins, G; Connor, S; Corte, C; Gounder, P; Kariyawasam, V; Katelaris, P; Koh, CE; Lawrance, IC; Lee, TW; Lemberg, DA; Leong, RW; McLachlan, A; Moore, GT; Moran, N; Paramsothy, S; Radford-Smith, G; Tattersall, S; Walsh, AJ | 1 |
Kugathasan, S; Romano, C; Syed, S; Valenti, S | 1 |
Alam, MF; Alrubaiy, L; Clement, C; Cohen, D; Grey, M; Hilton, M; Hutchings, HA; Longo, M; Morgan, JM; Rapport, FL; Seagrove, AC; Watkins, A; Williams, JG | 1 |
Gibson, R; Lees, CW; Lynch, RW; Pal, S; Soane, T | 1 |
Annese, V; Bagnoli, S; Caini, S; Deiana, S; Giannotta, M; Manetti, N; Scaringi, S | 1 |
D'Haens, G; Hindryckx, P; Jairath, V | 1 |
Alam, MF; Alrubaiy, L; Arnott, I; Clement, C; Cohen, D; Gordon, JN; Hawthorne, AB; Hilton, M; Hutchings, HA; Jawhari, AU; Longo, M; Mansfield, J; Morgan, JM; Rapport, F; Seagrove, AC; Sebastian, S; Shaw, I; Travis, SP; Watkins, A; Williams, JG | 1 |
Komaki, F; Komaki, Y; Micic, D; Sakuraba, A; Suzuki, Y; Yamada, A | 1 |
Cohen, BL; Dubinsky, MC; Naymagon, S; Sands, BE; Shah, SC | 1 |
Allez, M; Amiot, A; Bommelaer, G; Bouhnik, Y; Bourreille, A; Branche, J; Carbonnel, F; Coffin, B; Cosnes, J; de Vos, M; Dewit, O; Esteve, M; Farkkila, M; Filippi, J; Fumery, M; Gisbert, JP; Laharie, D; Lambert, J; Lopez-Sanroman, A; Louis, E; Marteau, P; Mary, JY; Moreau, J; Nahon, S; Ricart, E; Roblin, X; Savoye, G; van Assche, G; Vuitton, L; Zerbib, F | 1 |
Choi, CH; Han, DS; Jung, Y; Kim, ES; Kim, YS; Lee, BI; Lee, H; Moon, W; Park, DI; Yoon, YS | 1 |
Moss, AC; Peppercorn, MA | 1 |
Brugnera, R; Campieri, M; Gionchetti, P; Poggioli, G; Rizzello, F; Straforini, G; Tambasco, R | 1 |
Sands, BE | 2 |
Rutgeerts, P; Van Assche, G; Vermeire, S | 2 |
Caprilli, R | 1 |
Burakoff, R | 1 |
Deconda, D; Kornbluth, A; Lichtiger, S; Maser, EA; Present, DH; Ullman, T | 1 |
Ferrer Arranz, L; Huguet Malavés, JM; Medina Chuliá, E; Ruiz Sánchez, L | 1 |
Bourreille, A; Branche, J; Coffin, B; Colombel, JF; Cortot, A; de Saussure, P; de Vos, M; Lemann, M; Marteau, P; Seksik, P | 1 |
Al-Ali, M; Bojic, D; Jewell, DP; Nedeljkovic-Protic, M; Radojicic, Z; Travis, SP | 1 |
Cury, DB; Cury, Mde S; Elias, GV; Mizsputen, SJ | 1 |
Hinojosa del Val, J; Maroto Arce, N | 1 |
Casellas Jordá, F; Huamán Ríos, JW; Malagelada Benaprés, JR | 1 |
Ando, T; El-Omar, EM; Goto, H; Hasegawa, M; Ina, K; Ishiguro, K; Miyahara, R; Miyake, N; Nakamura, M; Niwa, Y; Ohmiya, N; Shimada, M; Watanabe, O | 1 |
Bastida, G; Domènech, E; Garcia-Planella, E; Gonzalez-Lama, Y; Hinojosa, J; López San Román, A; Mañosa, M; Masnou, H | 1 |
Koltun, WA | 1 |
Cheifetz, AS; Doherty, GA | 1 |
Al-Niaimi, F; Cox, NH | 1 |
Hawkins, N; Punekar, YS | 1 |
Holme, O; Thiis-Evensen, E; Vatn, MH | 1 |
Actis, GC; David, E; Pellicano, R; Sapino, A | 1 |
Lindenmann, N; Vorburger, D; Wieler, B | 1 |
George, BD; Mortensen, NJ; Randall, J; Singh, B; Travis, SP; Warren, BF | 1 |
Andoh, A; Bamba, S; Fujiyama, Y; Inatomi, O; Koizumi, Y; Nakahara, T; Saitoh, Y; Sasaki, M; Tsujikawa, T | 1 |
Hibi, T; Hisamatsu, T; Ichikawa, H; Inoue, N; Iwao, Y; Kanai, T; Kobayashi, T; Naganuma, M; Ogata, H; Okamoto, S | 1 |
Andronis, L; Bryan, S; Connock, M; Fry-Smith, A; Hyde, C; Wang, D | 1 |
Hibi, T; Hisamatsu, T; Ichikawa, H; Inoue, N; Iwao, Y; Kobayashi, T; Naganuma, M; Ogata, H; Okamoto, S; Saito, R; Sujino, T; Takayama, T | 1 |
Hart, AL; Ng, SC | 1 |
Iwakiri, R; Kitayama, A; Misago, N; Narisawa, Y; Okawa, T | 1 |
Cheifetz, AS; Garud, S; Goldstein, E; Malter, L; Moss, AC; Present, DH; Stern, J | 1 |
Angelberger, S; Dejaco, C; Gangl, A; Meshkat, M; Miehsler, W; Mikulits, A; Novacek, G; Reinisch, W; Vogelsang, H; Walch, A | 1 |
Fujii, T; Naganuma, M; Watanabe, M | 1 |
Farkas, K; Molnár, T; Nagy, F; Nyári, T; Szepes, Z; Wittmann, T | 1 |
Allez, M; Bouguen, G; Bouhnik, Y; Bourreille, A; Chaussade, S; Colombel, JF; Dewit, O; Duclos, B; Dupas, JL; Flourié, B; Leblanc, S; Lémann, M; Mary, JY; Michetti, P; Peeters, H; Peyrin-Biroulet, L; Saussure, P; Seksik, P | 1 |
Dubinsky, MC; Ford, AC; Khan, KJ; Moayyedi, P; Talley, NJ; Ullman, TA | 1 |
Burger, DC; Travis, S | 1 |
Angelberger, S; Blomquist, L; Dejaco, C; Friis-Liby, I; Grännö, C; Gustavsson, A; Halfvarson, J; Hellström, PM; Hertervig, E; Järnerot, G; Karlen, P; Magnuson, A; Meshkat, M; Novacek, G; Reinisch, W; Sjöberg, M; Ström, M; Tysk, C; Verbaan, H; Vilien, M; Vogelsang, H; Walch, A | 1 |
Bredin, F; Nightingale, A; Parkes, M; Sharkey, L | 1 |
Avellini, C; Fabro, M; Fiorino, G; Sorrentino, D; Szabo, H; Tabuso, M; Terrosu, G | 1 |
Lahiff, C; Moss, AC | 1 |
Blumenstein, I; Bock, H; Dignass, A; Filmann, N; Hartmann, F; Herrmann, E; Schröder, O; Stein, J; Tacke, W; Zeuzem, S; Zosel, C | 1 |
Actis, GC; Daperno, M | 1 |
Büning, J; Fellermann, K | 1 |
Hirayama, M; Iyama, S; Kato, J; Kobune, M; Kuroiwa, G; Murase, K; Okamoto, T; Sagawa, T; Sato, T; Sato, Y; Takada, K; Takahashi, S; Takimoto, R; Tanaka, S | 1 |
Meier, J; Sturm, A | 1 |
Xinmei, Z; Yan, C | 1 |
Cottone, M; Maida, M; Orlando, A; Renna, S; Sinagra, E | 1 |
Barreiro-de-Acosta, M; Campos-Franco, J; Losada-Ares, L; Pérez-Pampín, E | 1 |
Dean, KE; Hikaka, J; Huakau, JT; Walmsley, RS | 1 |
Bell, SJ; Brown, SJ; Chan, FK; Chan, H; Chow, DK; Connell, WR; De Cruz, P; Desmond, PV; Kamm, MA; Leong, RW; Lust, M; Ng, SC; Prideaux, L; Sung, JJ; Williams, J; Wu, JC | 1 |
Bitton, A; Buie, D; Enns, R; Feagan, BG; Griffiths, AM; Jones, JL; Marshall, JK; Panaccione, R; Whittaker, S | 1 |
Suzuki, Y | 1 |
Barreiro-de Acosta, M; Bastida, G; Burgueño, P; Calvet, X; Castro, L; Chaparro, M; García-Planella, E; Gisbert, JP; Gómez, M; Gomollón, F; Hernández, V; Hinojosa, J; Iglesias, E; Jiménez, C; Mañosa, M; Mendoza, JL; Muñoz, F; Nyssen, OP; Panés, J; Senent, SG | 1 |
Sachar, DB | 1 |
Falvey, JD; Gearry, RB | 1 |
Cottone, M; Mocciaro, F; Orlando, A; Orlando, E; Renna, S; Rizzuto, G; Sinagra, E | 1 |
Ben-Horin, S; de Haar, C; Ehehalt, R; Higgins, P; Karrasch, T; Latella, G; Rieder, F; Rogler, G; Sans, M; Scaldaferri, F; Schirbel, A; Velin, D; Wehkamp, J | 1 |
Farkas, K; Gecse, K; Horváth, G; Lázár, G; Molnár, T; Nagy, F; Nyári, T; Szepes, Z; Wittmann, T | 1 |
Cohen, SA; Ferry, GD; Gold, BD; Gupta, N; Heyman, MB; Jen, HC; Kelley-Quon, LI; Kirschner, BS; Shew, SB; Winter, HS; Ziring, DA | 1 |
Atreya, R; Neumann, H; Neurath, MF | 1 |
Arai, M; Katsuno, T; Matsubara, H; Matsumura, T; Miyauchi, H; Nakagawa, T; Saito, K; Saito, M; Sato, T; Sazuka, S; Yokosuka, O | 1 |
Hiraoka, S; Kato, J; Suzuki, H; Yamamoto, K | 1 |
Levesque, BG; Sandborn, WJ | 1 |
Allez, M; Bommelaer, G; Bouhnik, Y; Bourreille, A; Branche, J; Carbonnel, F; Coffin, B; Colombel, JF; Cosnes, J; de Vos, M; Delchier, JC; Dewit, O; Dupas, JL; Esteve, M; Färkkilä, M; Filippi, J; Franchimont, D; Gisbert, JP; Laharie, D; Lémann, M; Lopez-Sanroman, A; Marteau, P; Mary, JY; Moreau, J; Nachury, M; Nahon, S; Ricart, E; Roblin, X; Savoye, G; Van Assche, G; Zerbib, F | 1 |
Rolny, P; Vatn, M | 1 |
Burke, JP; Chang, KH; Coffey, JC | 1 |
Hart, AL; Peake, ST | 1 |
Domènech, E; Gisbert, JP | 1 |
Kaur, M; Targan, SR | 1 |
Stange, EF | 1 |
Ford, AC; Hanauer, SB; Moayyedi, P | 1 |
Pikarsky, A; Wexner, SD; Zmora, O | 1 |
Cummins, AG; Rodgers, NG; Teo, M | 1 |
Hyland, JM; McCormack, G; McCormick, PA; O'Donoghue, DP | 1 |
Cohen, RD | 2 |
Bernal, I; Boix, J; Cabré, E; Domènech, E; Fluvià, L; Garcia-Planella, E; Gassull, MA; Rosinach, M | 1 |
Lichtenstein, GR; Su, C | 1 |
Loftus, CG; Loftus, EV; Sandborn, WJ | 1 |
Hawthorne, AB | 1 |
Folwaczny, C; Rath, HC | 1 |
Bailey, RJ; Lam, EC | 1 |
Bouhnik, Y | 1 |
Hanauer, SB; Present, DH | 1 |
Campieri, M; Gionchetti, P; Rizzello, F; Venturi, A | 1 |
Blanshard, C; Dor, R | 1 |
Lonovics, J; Molnár, T; Nagy, F; Szepes, Z | 1 |
Hirano, E; Ishii, H; Kishikawa, H; Morishita, T; Nakano, M; Nishida, J | 1 |
Emmanuel, AV; Kamm, MA; McCormack, G; Rayner, CK | 1 |
Arts, J; Asnong, K; D'Haens, G; D'Hoore, A; Hiele, M; Noman, M; Penninckx, F; Rutgeerts, P; Van Assche, G; Vermeire, S | 1 |
Campbell, S; Ghosh, S | 1 |
Leiper, K; Thuraisingam, A | 1 |
Kamm, MA | 1 |
Daperno, M; Ercole, E; Pera, A; Rigazio, C; Rocca, R; Scaglione, N; Sostegni, R | 1 |
Actis, GC; Fadda, M; Lagget, M; Morino, F; Palmo, A; Pinna-Pintor, M; Rizzetto, M | 1 |
Angeloni, G; Gasbarrini, G; Latteri, M; Manna, R; Navarra, P; Rumi, C | 1 |
Lonovics, J; Molnár, T; Nagy, F; Szenohradszki, P; Szepes, Z | 1 |
Fennell, JM; Goddard, CJ; Ho, GT; Mowat, C; Prescott, RJ; Satsangi, J; Shah, NB | 1 |
Hanauer, SB | 3 |
Arts, J; D'Haens, G; D'Hoore, A; Hiele, M; Penninckx, F; Rutgeerts, P; Van Assche, G; Vermeire, S; Zeegers, M | 1 |
Regueiro, M | 1 |
Chang, JC; Cohen, RD | 1 |
Date, H; Eto, T; Inatsu, H; Ishikawa, N; Kitani, M; Murata, S; Ootsuka, M; Oshikawa, S; Yamaga, J | 1 |
Bonvoisin, SC; Cenni, JC; Descos, L; Flourié, B; Moussata, D; Nancey, S | 1 |
Bebb, JR; Scott, BB | 1 |
Besisik, F; Boztas, G; Cakaloglu, Y; Danalioglu, A; Demir, K; Durakoglu, Z; Karaca, C; Kaymakoglu, S; Mungan, Z; Okyen, A | 1 |
Meng, SY; Pan, BR; Xu, CT | 1 |
Angriman, I; Benazzato, L; D'Incà, R; Grigoletto, F; Medici, V; Perissinotto, E; Sturniolo, GC | 1 |
Gould, S; Jayaprakash, A; Lim, AG; Shehata, HA | 1 |
Chebli, JM; da Silva, CE; de Souza, AF; Felga, GE; Gaburri, PD; Pinto, JR | 1 |
Bischoff, SC; Fleig, W; Reissmann, A | 1 |
Bruch, HP; Hoffmann, JC; Schwandner, O | 1 |
Dejaco, C; Knoflach, P; Petritsch, W; Reinisch, W; Tilg, H; Vogelsang, H | 1 |
Fridlender, ZG; Rottenberg, Y | 1 |
Cohen, RD; Ross, AS | 1 |
Gil, F; Gironella, M; Massaguer, A; Panés, J; Piqué, JM; Salas, A; Soriano-Izquierdo, A | 1 |
Campbell, S; Jewell, D; Travis, S | 1 |
Brezis, M; Regushevskaya, E; Shibolet, O; Soares-Weiser, K | 1 |
Böhm, M; Ecker, KW; Giese, T; Jüngling, B; Kindermann, I; Moser, C; Püschel, W; Schäfers, HJ; Stallmach, A; Zeuzem, S | 1 |
Lindley, KJ; Milla, PJ; Ramsay, AD; Shah, N; Thapar, N | 1 |
Alamdari, A; Bourreille, A; Galmiche, JP; Laharie, D; Lamouliatte, H; Message, L; Quinton, A; Zerbib, F | 1 |
Hibi, T; Hisamatsu, T | 2 |
Al-Shekhlee, A; Katirji, B; Oghlakian, G | 1 |
Hollenbeak, CS; Koltun, WA; Poritz, LS; Rowe, WA; Swenson, BR | 1 |
Matsui, T | 1 |
de Saussure, P; Hadengue, A; Morel, P; Soravia, C | 1 |
De Santis, M; Ferraccioli, GF; Tomietto, P | 1 |
Gil, D; Latocha, M; Mazurek, U; Stadnicki, A | 1 |
Durai, D; Hawthorne, AB | 1 |
Akiyama, S; Ando, T; Goto, H; Hibi, K; Ina, K; Ito, K; Kodera, Y; Komatsu, Y; Kusugami, K; Nagasaka, T; Nakao, A | 1 |
Abela, CB; Gateley, D; Soldin, M | 1 |
Berardi, RR; Efros, CB; Pham, CQ | 1 |
García-López, S; Gomollón-García, F; Pérez-Gisbert, J | 1 |
Hinojosa, J; Nos, P | 1 |
Järnerot, G | 1 |
Dijkstra, G; Kleibeuker, JH; Ploeg, RJ; van Dullemen, HM; Weersma, RK | 1 |
Domènech, E; Gassull, MA; Gomollón, F; Obrador, A; Panés, J | 1 |
Matsui, H; Miyazaki, K; Nakahara, A; Sato, D; Shibahara, T; Tanaka, N; Yanaka, A | 1 |
Alexender, G; Ghoshal, U; Ghoshal, UC; Krishnani, N; Tripathi, S | 1 |
Creed, TJ; Dayan, CM; Hearing, SD; Moorghen, M; Norman, MN; Probert, CS; Shepherd, NA | 1 |
Arts, J; Ferrante, M; Maenhout, B; Moskovitz, DN; Rutgeerts, P; Van Assche, G; Vermeire, S | 1 |
Arseneau, KO; Bickston, SJ; Cominelli, F; Connors, AF; Foley, E; Onken, J; Provenzale, DT; Sultan, S | 1 |
Maeda, M; Nakamura, F; Nakashima, Y; Naruse, K; Ohno, O; Okamura, S; Takeuchi, T; Tomida, T | 1 |
Chadburn, A; Coleman, M; Kim, MK; Lichtiger, S; Scherl, E; Schwartz, LK | 1 |
Angelberger, S; Dejaco, C; Reinisch, W | 1 |
Castro, M; Ceriati, E; De Angelis, P; De Peppo, F; Diamanti, A; Ferretti, F; Gambarara, M; Knafelz, D; Papadatou, B; Rivosecchi, M | 1 |
Cheon, JH; Chung, GE; Jung, HC; Kim, JS; Kim, SG; Lee, JY; Song, IS; Ye, BD | 1 |
Jeen, YT; Keum, B | 1 |
Carbonnel, F; Dupont-Gossart, AC; Fein, F; Heyd, B; Koch, S; Mantion, G; Weber, A | 1 |
Griffiths, AM; Steinhart, AH; Turner, D; Walsh, CM | 1 |
Hibi, T; Hisamatsu, T; Ichikawa, H; Inoue, N; Iwao, Y; Izumiya, M; Matsuoka, K; Mori, T; Morohoshi, Y; Ogata, H; Okamoto, S; Sakuraba, A; Sato, T; Yajima, T | 1 |
Beaune, P; Boureille, A; Cosnes, J; Daniel, F; De Vos, M; Fein, F; Flourié, B; Gornet, JM; Lémann, M; Loriot, MA; Louis, E; Marteau, P; Roblin, X; Seksik, P; Treton, X; Vernier-Massouille, G; Zerbib, F | 1 |
Bousvaros, A; Hait, EJ; Lillehei, CW; Schuman, M; Shamberger, RC | 1 |
Araki, A; Chin, S; Itsui, Y; Kanai, T; Kawamura, T; Kubota, D; Matsumoto, T; Miyata, T; Nagahori, M; Okada, E; Ooka, S; Sakamoto, N; Tsuchiya, K; Watanabe, M; Yui, F | 1 |
Caprilli, R; Latella, G; Viscido, A | 1 |
Ando, T; Goto, H; Minami, M; Niwa, Y; Ohkura, T; Ohmiya, N; Ohta, M | 1 |
Ainsworth, MA; Brynskov, J | 1 |
Actis, GC; David, E; Fadda, M; Sapino, A | 1 |
Carbonnel, F | 1 |
Huber, W; Reindl, W; Schmid, RM | 1 |
Lakatos, L; Lakatos, PL | 1 |
Hibi, T; Ogata, H | 1 |
Dubinsky, M; Fleshner, PR; Ippoliti, A; Mei, L; Papadakis, KA; Schluender, SJ; Targan, SR; Vasiliauskas, EA | 1 |
Guardiola, J; Rodríguez-Moranta, F; Soriano-Izquierdo, A | 1 |
Afchain, P; Beaugerie, L; Cacheux, W; Cosnes, J; Daniel, F; Lemann, M; Marteau, P; Nion-Larmurier, I; Seksik, P | 1 |
Aceituno, M; Domènech, E; Feu, F; García-Planella, E; Gassull, MA; Heredia, C; Panés, J; Zabana, Y | 1 |
Dalal, L | 1 |
Girelli, CM; Rocca, E; Rocca, F; Serio, G | 1 |
Baudet, A; Bretagne, AL; Gloro, R; Justum, AM; Rahmi, G; Reimund, JM | 1 |
Lichtiger, S | 1 |
Carbonnel, F; Dupont-Gossart, AC; Herbein, G; Mantion, G; Piton, G; Viennet, G; Weber, A | 1 |
Kornbluth, A; Swaminath, A | 1 |
Ando, T; Goto, H; Ishiguro, K; Ishikawa, D; Maeda, O; Nishio, Y; Niwa, Y; Ohmiya, N; Takahashi, H; Watanabe, O | 1 |
Dittrich, K; Köhler, H; Rascher, W; Richter, M | 1 |
Kane, SV; Kornbluth, AA; Murphy, SJ; Present, DH; Reddy, D | 1 |
Durá Ayet, AB; Ferrer Arranz, L; Huguet Malavés, JM; Latorre Sánchez, M; Medina Chuliá, E; Rodríguez García, I; Ruiz Sánchez, L; Tomé Toyosato, A; Tuset Ruiz, JA | 1 |
Bernal, I; Boix, J; Cabré, E; Domènech, E; Garcia-Planella, E; Gassull, MA; Hernández, A; Ojanguren, I; Rosinach, M; Vega, R | 1 |
Ambo, T; Hagiwara, T; Imamura, A; Kozawa, H; Kurokawa, S; Motoya, S; Nakagaki, S; Nishioka, H; Tanaka, H; Tsuya, R | 1 |
Fleshner, PR; Hanauer, SB; Michelassi, F; Plevy, SE; Rubin, M; Targan, SR | 1 |
Brazier, F; Duchmann, JC; Dupas, JL; Finet, L | 1 |
Fischbach, W | 1 |
Korelitz, BI | 1 |
Purdum, PP; Sanyal, AJ | 1 |
Sandborn, WJ | 1 |
Baudet, S; Casellas, F; Guarner, L; Malagelada, JR; Santos, J; Vilaseca, J | 1 |
Crippin, J; Goldstein, R; Gonwa, TA; Holman, M; Husberg, B; Klintmalm, G; Stephens, J | 1 |
Glaspy, JA; Grody, WW; Slater, ED; Storek, J; Susi, E | 1 |
Bertschinger, P; Follath, F; Himmelmann, A; Risti, B | 1 |
Cohen, J; Davis, PM; Hyams, JS; Justinich, CJ; Treem, WR | 1 |
Benkov, KJ; Janowitz, HD; LeLeiko, NS; Rosh, JR; Schwersenz, AH | 1 |
La Tulippe Naccarini, DA; Minor, ML | 1 |
Gendre, JP | 1 |
Ament, ME; Vargas, JH | 1 |
van Hogezand, RA | 1 |
Axon, AT; Crabtree, JE; Dixon, MF; Jones, SC; Rembacken, BJ; Trejdosiewicz, LK; Whicher, JT | 1 |
Bensousan, TA; Vincent, F | 1 |
Hyams, JS; Treem, WR | 1 |
Hughes, LE; Tjandra, JJ | 1 |
Arase, K; Asayama, R; Dohmen, K; Ishibashi, H; Kuroki, F; Nakamura, H; Nojiri, I; Shigematsu, H; Takahashi, M; Yokogawa, Y | 1 |
Batts, KP; Harrison, JM; Lawson, GM; Sandborn, WJ; Schroeder, KW; Steiner, BL; Tremaine, WJ; Zinsmeister, AR | 1 |
Bauer, J; Galler, G; Gelernt, I; Hanauer, S; Kornbluth, A; Lichtiger, S; Michelassi, F; Present, DH | 1 |
Sartor, RB | 1 |
Eherer, A; Krejs, GJ; Petritsch, W; Reicht, G; Wenzl, H | 1 |
Campbell, A; Dalton, HR; Jewell, DP; Merrett, MN; Winter, TA | 1 |
Brynskov, J | 2 |
Humphreys, TR; Leyden, JJ | 1 |
Cooper, HS; Ibrahim, SA; Murthy, SN; Sedergran, DJ; Shah, RS; Shim, H | 1 |
Actis, GC; Barletti, C; Ottobrelli, A; Pera, A; Pinna-Pintor, M; Ponti, V; Verme, G | 1 |
Daum, F; Grancher, K; Mandel, F; Markowitz, J | 1 |
Allgayer, H; Gugler, R; Seitz, KH | 1 |
Larusso, NF; Sandborn, WJ; Tremaine, WJ; Wiesner, RH | 1 |
Hyams, JS; Rotter, JI; Targan, SR; Treem, WR; Veligati, LN | 1 |
Present, DH | 1 |
Batts, KP; Lawson, GM; Sandborn, WJ; Schroeder, KW; Steiner, BL; Tremaine, WJ | 1 |
Chakravarty, BJ | 1 |
Bedard, C; Bredfeldt, J; Brentnall, T; Gelfand, M; Greene, M; Justus, P; Kozarek, R; Patterson, D; Putnam, W; Sandford, R | 1 |
Actis, GC; Balzola, F; Boggio-Bertinet, D; Bonino, F; Debernardi-Venon, W; Lagget, M; Marzano, A; Ottobrelli, A; Ponzetto, A; Rocca, G | 1 |
Calenda, K; Grand, RJ; Langhans, N; Ramakrishna, J; Verhave, M | 1 |
Brynskov, J; Rasmussen, SN | 1 |
Aubertin, JM; Becheur, H; Bloch, F; Chapat, O; Levoir, D; Milhade, JF; Petite, JP | 1 |
Lémann, M | 1 |
Andant, C; Edery, J; Fouchard, I; Pouchot, J; Soulé, JC | 1 |
van Hogezand, RA; Verspaget, HW | 1 |
Lichtenstein, GR; Stotland, BR | 1 |
Bertrán, X; Cabré, E; Esteve-Comas, M; Fernández-Bañares, F; Gassull, MA; Humbert, P; Menacho, M; Planas, R | 1 |
Farrant, JM; Jewell, DP; Kettlewell, MG; Mortensen, NM; Nolan, DJ; Ricketts, C; Travis, SP | 1 |
Benvenuti, C; Cadranel, JF; Cazier, A; Coutarel, P; Devergie, B; Loison, P; Lukombo-Ndudi, S | 1 |
Belaïche, J; Boruchowicz, A; Carbonnel, F; Colombel, JF; Cosnes, J; Duclos, B; Gendre, JP; Lémann, M; Lerebours, E; Soulé, JC | 1 |
Hicks, BH; Quan, VA; Saunders, BP; Sladen, GE | 1 |
Casà, A; Cottone, M; Oliva, L; Orlando, A; Rosselli, M | 1 |
Ackerman, Z; Eliakim, R; Rachmilewitz, D; Stalnikowich, R; Symon, Z | 1 |
Harms, BA; Myers, GA; Scott, AM | 1 |
Hanauer, S; Kornbluth, A; Lichtiger, S; Present, DH | 1 |
Marion, JF; Present, DH | 1 |
Schölmerich, J | 1 |
Modigliani, R | 2 |
Cammarota, G; Cuoco, L; Fedeli, G; Gasbarrini, G; Papa, A; Tursi, A | 1 |
Atkinson, KA; Feagan, BG; Lamba, B; McDonald, JW | 1 |
Roy, MA | 1 |
Baert, F; Rutgeerts, P | 2 |
Baumann, R; Duclos, B; Reimund, JM | 1 |
D'Haens, G; Rutgeerts, P; Suenaert, P; Westhovens, R | 1 |
Connell, WR; d'Apice, AJ; Elliott, R; Taylor, AC | 1 |
Aichbichler, BW; Fleischmann, G; Hinterleitner, TA; Krejs, GJ; Petritsch, W; Wenzl, HH | 1 |
Hyde, GM; Jewell, DP; Thillainayagam, AV | 1 |
Baptista, C; Canena, J; Dias, R; Leitão, J; Penedo, J; Pinto, A; Quina, M; Ramos, M; Reis, J; Santos, AM; Turpin, S | 1 |
Furuta, T; Futami, H; Hanai, H; Kaneko, E; Kodaira, M | 1 |
Oppong, K; Record, CO | 1 |
Linskens, RK; Sindram, JW; Tuynman, HA; van Bodegraven, AA; van Haelst, IM | 1 |
Hassan, M; Kashimura, H; Matsumaru, K; Muto, H; Nakahara, A; Shibahara, K; Suzuki, K; Tanaka, N; Yanaka, A | 1 |
Grand, RJ | 1 |
David-Walek, T; Fellermann, K; Ludwig, D; Stahl, M; Stange, EF | 1 |
Dejaco, C; Gangl, A; Gasché, C; Moser, G; Novacek, G; Reinisch, W; Tillinger, W; Vogelsang, H | 1 |
Hawkey, CJ; Long, RG; Stack, WA | 1 |
Burroughs, AK; Davidson, B; Hamilton, M; Mistry, PK; Papatheodoridis, GV; Rolles, K | 1 |
Actis, GC; Aimo, G; Moscato, D; Pagni, R; Priolo, G; Rizzetto, M | 1 |
Tremaine, WJ | 1 |
Brodsky, AL; Cohen, RD; Hanauer, SB | 1 |
Bertrán, X; Cabré, E; Domènech, E; Gassull, MA; Hombrados, M; Menacho, M; Moreno de Vega, V; Ojanguren, I; Vega, R | 1 |
Logan, RF; Stack, WA; Stevenson, M; Williams, D | 1 |
Cohen, RD; Hanauer, SB; Stein, R | 1 |
Hanauer, SB; Stein, RB | 1 |
Carrasco, FJ; Domínguez Macías, A; Ferrer Ríos, T; Garrido Mora, M; Pallarés Manrique, H; Pérez Gómez, MB; Ramos Lora, M | 1 |
Das, KM; Gialanella, RJ; Griffel, LH; Gurudu, SR | 1 |
Actis, GC; Rizzetto, M; Volpes, R | 1 |
Katsumata, S; Miyaoka, M; Saito, T; Shiratori, T | 1 |
Arimura, Y; Endo, T; Imai, K | 1 |
Kougo, Y | 1 |
Ebinuma, H; Hibi, T; Hisamatsu, T; Ishii, H; Iwao, Y; Kashiwagi, K; Miyazaki, K; Takaishi, H; Watanabe, M; Yajima, T | 1 |
Colombel, JF; Desreumaux, P; Ectors, N; Geboes, K; Jouret, A; Rutgeerts, P | 1 |
Camacho-Martinez, F; Muñoz-Pérez, MA; Sotillo-Gago, I | 1 |
Hadziyannis, S; Koskinas, J; Manika, Z; Raptis, I | 1 |
Actis, GC | 2 |
Aguilera, V; Berenguer, J; Nos, P; Ortiz, V; Ponce, J | 1 |
Actis, GC; Arese, P; Bona, R; Falletto, E; Lagget, M; Marzano, A; Massaioli, N; Ottobrelli, A; Pinna-Pintor, M; Rizzetto, M; Schieroni, R; Selvaggi, P; Sostegni, R; Torrani-Cerenzia, MR; Villata, E | 1 |
Hinterreiter, M; Knoflach, P; Stadler, B | 1 |
McHugh, J; Moore, CP; Phillips, TE | 1 |
Karp, LC; Plevy, SE; Rowe, FA; Targan, SR; Vasiliauskas, EA; Walker, JH | 1 |
Blomberg, B; Järnerot, G | 1 |
Avidan, B; Avni, Y; Bujanover, Y; Fireman, Z; Leichtman, G; Maor, Y; Moskowitz, M; Naftali, T; Novis, B; Pomeranz, I; Shapiro, R | 1 |
Arber, N; Strul, H | 1 |
Caroli, A; D'Incà, R; Di Falco, G; Fregonese, D | 1 |
Egan, LJ; Lipsky, JJ; Mays, DC; Sandborn, WJ; Tremaine, WJ | 1 |
Van Gossum, A | 1 |
Cho, CH; Guo, X; Ko, JK; Sham, NF | 1 |
D'Haens, G; Geboes, K; Hiele, M; Lemmens, L; Mortelmans, L; Nevens, F; Peeters, M; Penninckx, F; Rutgeerts, P; Van Acker, F; Vandeputte, L; Vermeire, S | 1 |
Baird, A; McCormack, G; O'Donoghue, D | 1 |
Avilés, J; de las Casas, D; Dorta, MC; Morales, S; Navazo, L; Pérez, F; Salata, H | 1 |
Hawkey, CJ; Logan, RP; Mahida, YR; Richardson, PD; Stack, WA | 1 |
Angeloni, G; Gasbarrini, G; Latteri, M; Manna, R; Navarra, P; Silveri, NG | 1 |
Actis, GC; Astegiano, M; Boscaglia, C; Bresso, F; Demarchi, B; Rizzetto, M; Sapone, N | 1 |
Kjeldsen, J; Knudsen, T; Wilson, BV | 1 |
Hyde, GM; Jewell, DP; Kettlewell, MG; Mortensen, NJ | 1 |
Leighton, JA | 1 |
Chiba, T; Inomata, M; Orii, S; Saito, S; Sannohe, I; Shitomi, T; Suzuki, K | 1 |
Druschky, A; Druschky, K; Erbguth, F; Heckmann, JG; Huk, WJ; Neundörfer, B | 1 |
Hirayama, M; Kato, J; Kawano, Y; Niitsu, Y; Nishisato, T; Okamoto, T; Okubo, S; Sakamaki, S; Takayama, T; Yamauchi, N; Yoshizaki, N | 1 |
Ando, T; Binion, DG; Imada, A; Ina, K; Kusugami, K; Nishio, Y; Shimada, M; Tsuzuki, T | 1 |
Strong, SA | 1 |
Falasco, G; Forbes, A; Zinicola, R | 1 |
Bonanomi, AG; Celli, A; d'Albasio, G; Stio, M; Tarantino, O; Treves, C | 1 |
Rolny, P; Sadik, R | 1 |
Castellino, F; Daperno, M; Ercole, E; Pera, A; Rigazio, C; Rocca, R; Scaglione, N; Sostegni, R | 1 |
Distler, A; Passfall, J; Riecken, EO; Zeitz, M | 1 |
Goldman, DH; Lawson, GM; Perrault, J; Sandborn, WJ | 1 |
Sandborn, WJ; Tremaine, WJ | 1 |
Belaiche, J; Delwaide, J; Gast, P; Louis, E | 1 |
Hanauer, SB; Smith, MB | 1 |
Hodgson, HJ | 1 |
Dalton, HR; Jewell, DP | 1 |
Davis, PM; Hyams, JS; Treem, WR | 1 |
119 review(s) available for cyclosporine and Colitis Gravis
Article | Year |
---|---|
Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis.
Topics: Adrenal Cortex Hormones; Beclomethasone; Colitis, Ulcerative; Cyclosporine; Humans; Proctitis; Remission Induction; Suppositories; Tacrolimus | 2022 |
Acute Severe Ulcerative Colitis: Optimal Strategies for Drug Therapy.
Topics: Acute Disease; Adrenal Cortex Hormones; Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Infliximab; Treatment Outcome | 2023 |
Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis.
Topics: Colitis, Ulcerative; Cost-Benefit Analysis; Cost-Effectiveness Analysis; Cyclosporine; Humans; Infliximab; Network Meta-Analysis; Quality-Adjusted Life Years; Tacrolimus; Treatment Outcome | 2022 |
Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Review.
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Steroids; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Ustekinumab | 2023 |
Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.
Topics: Abortion, Spontaneous; Adult; Antiviral Agents; Betacoronavirus; C-Reactive Protein; Clinical Laboratory Techniques; Colitis, Ulcerative; Coronavirus Infections; COVID-19; COVID-19 Testing; Cyclosporine; Female; Humans; Immunosuppressive Agents; Methylprednisolone; Pandemics; Patient Acuity; Pneumonia, Viral; Pregnancy; Pregnancy Complications; Remission Induction; SARS-CoV-2; Sigmoidoscopy; Treatment Outcome | 2020 |
The management of the hospitalized ulcerative colitis patient: the medical-surgical conundrum.
Topics: Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Infliximab; Proctocolectomy, Restorative | 2020 |
Inflammatory Bowel Disease - Non-biological treatment.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Digestive System Surgical Procedures; Gastrointestinal Agents; Humans; Mesalamine; Methotrexate; Tacrolimus; Treatment Outcome | 2020 |
Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis.
Topics: Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Remission Induction; Tacrolimus; Treatment Outcome | 2020 |
Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
Topics: Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Remission Induction | 2021 |
Acute severe ulcerative colitis: management advice for internal medicine and emergency physicians.
Topics: Adrenal Cortex Hormones; Colitis, Ulcerative; Cyclosporine; Emergency Medicine; Humans; Immunosuppressive Agents; Infliximab; Internal Medicine; Radiography; Treatment Outcome | 2021 |
Infliximab versus cyclosporine for severe ulcerative colitis refractory to steroids: A protocol for systematic review and meta-analysis.
Topics: Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Randomized Controlled Trials as Topic; Research Design; Systematic Reviews as Topic | 2018 |
Optimal management of acute severe ulcerative colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Colectomy; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Risk Assessment | 2019 |
Ulcerative colitis - treatment with biologicals.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Brazil; Clinical Decision-Making; Colitis, Ulcerative; Cyclosporine; Humans; Infliximab; Remission Induction; Treatment Outcome | 2019 |
Update on pregnancy and breastfeeding in the era of biologics.
Topics: Adalimumab; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Breast Feeding; Certolizumab Pegol; Colitis, Ulcerative; Contraindications; Crohn Disease; Cyclosporine; Female; Fertility; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Natalizumab; Polyethylene Glycols; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Tacrolimus | 2013 |
What is the importance of infliximab and cyclosporine in the treatment of corticosteroid-refractory severe ulcerative colitis?
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Severity of Illness Index | 2012 |
Review article: strategies for the management of chronic unremitting ulcerative colitis.
Topics: Adalimumab; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Clinical Trials as Topic; Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Remission Induction; Tacrolimus; Treatment Outcome | 2013 |
[Treatment of patients with severe glucocorticoid-refractory ulcerative colitis: cyclosporine or infliximab?].
Topics: Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Glucocorticoids; Humans; Infliximab; Postoperative Complications; Treatment Outcome | 2013 |
Treatment of ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha | 2014 |
Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Substitution; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Salvage Therapy; Severity of Illness Index; Tacrolimus; Treatment Failure | 2014 |
[Biological agents in ulcerative colitis. When to prescribe].
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Biological Products; Child; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Double-Blind Method; Drug Resistance; Humans; Immunosuppressive Agents; Infliximab; Multicenter Studies as Topic; Observational Studies as Topic; Proctitis; Randomized Controlled Trials as Topic; Tumor Necrosis Factor-alpha | 2011 |
Natural history of first episode of acute severe colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Diagnosis, Differential; Disease Progression; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Risk Factors | 2014 |
Cyclosporine in steroid refractory acute severe colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous | 2014 |
Surgical and medical treatment in patients with acute severe ulcerative colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Colectomy; Colitis, Ulcerative; Cyclosporine; Emergency Medical Services; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Severity of Illness Index; Treatment Outcome | 2015 |
Review article: the practical management of acute severe ulcerative colitis.
Topics: Acute Disease; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Randomized Controlled Trials as Topic; Salvage Therapy; Steroids; Treatment Outcome | 2016 |
Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Gastrointestinal Agents; Humans; Infliximab; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Treatment Outcome; Young Adult | 2016 |
Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids.
Topics: Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Steroids | 2016 |
Review article: acute severe ulcerative colitis - evidence-based consensus statements.
Topics: Australia; Colectomy; Colitis, Ulcerative; Consensus; Cyclosporine; Hospitalization; Humans; Infliximab; Venous Thromboembolism | 2016 |
Management of Acute Severe Colitis in Children With Ulcerative Colitis in the Biologics Era.
Topics: Adrenal Cortex Hormones; Biological Products; Calcineurin Inhibitors; Child; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Gastrointestinal Agents; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Severity of Illness Index; Tacrolimus | 2016 |
Acute severe ulcerative colitis: from pathophysiology to clinical management.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Algorithms; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Calcineurin Inhibitors; Clinical Trials as Topic; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Disease Models, Animal; Electrolytes; Humans; Infliximab; Parenteral Nutrition; Salvage Therapy; Thromboembolism; Treatment Outcome; Tumor Necrosis Factor-alpha | 2016 |
Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: A network meta-analysis.
Topics: Colitis, Ulcerative; Cyclosporine; Databases, Bibliographic; Hospitalization; Humans; Infliximab; Randomized Controlled Trials as Topic; Severity of Illness Index; Tacrolimus; Treatment Outcome | 2017 |
[Second Korean Guideline for the Management of Ulcerative Colitis].
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; C-Reactive Protein; Colitis, Ulcerative; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Parenteral Nutrition; Prednisolone; Severity of Illness Index; Steroids; Tumor Necrosis Factor-alpha | 2017 |
Steroid-refractory severe ulcerative colitis: what are the available treatment options?
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Basiliximab; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Recombinant Fusion Proteins; Tacrolimus | 2008 |
Treatment of severe steroid refractory ulcerative colitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Drug Administration Routes; Drug Resistance; Gastrointestinal Agents; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Practice Guidelines as Topic; Severity of Illness Index; Treatment Failure | 2008 |
Management of acute severe ulcerative colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Clinical Protocols; Colitis, Ulcerative; Colonic Pouches; Cyclosporine; Digestive System Surgical Procedures; Drug Resistance; Gastrointestinal Agents; Humans; Infliximab; Patient Selection; Proctocolectomy, Restorative; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2009 |
Infliximab for the treatment of acute exacerbations of ulcerative colitis.
Topics: Acute Disease; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cost-Benefit Analysis; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Models, Economic; Quality of Life; Risk; Survival Analysis; Treatment Outcome | 2010 |
Review article: the optimal medical management of acute severe ulcerative colitis.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Management of acute severe ulcerative colitis.
Topics: Acute Disease; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Treatment Outcome | 2011 |
The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Calcineurin Inhibitors; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Tacrolimus | 2011 |
Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Injections, Intramuscular; Mercaptopurine; Methotrexate; Remission Induction; Secondary Prevention; Treatment Failure | 2011 |
Colon salvage therapy for acute severe colitis: cyclosporine or infliximab?
Topics: Acute Disease; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Salvage Therapy | 2011 |
Acute severe colitis: infliximab and/or cyclosporine?
Topics: Acute Disease; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Randomized Controlled Trials as Topic | 2011 |
[Intensive care and inflammatory bowel diseases (IBD). The severe and fulminant flare].
Topics: Algorithms; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Critical Care; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Interdisciplinary Communication; Patient Care Team; Tacrolimus; Tumor Necrosis Factor-alpha | 2011 |
Current treatment of ulcerative colitis.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Endoscopy; Gastroenterology; Humans; Infliximab; Mercaptopurine; Mesalamine; Remission Induction; Steroids; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
[The new treatment of intractable ulcerative colitis].
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Humans; Infliximab; Steroids; Tacrolimus | 2011 |
Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Butyric Acid; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Defensins; Extracellular Matrix; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Leptin; Matrix Metalloproteinases; Mesalamine; Paneth Cells; Probiotics; Reactive Nitrogen Species; Reactive Oxygen Species; Sulfasalazine; Tumor Necrosis Factor-alpha; Wound Healing | 2012 |
[Rational treatment of ulcerative colitis--local or systemic therapy? Surgery?].
Topics: Administration, Oral; Administration, Rectal; Adrenal Cortex Hormones; Algorithms; Anti-Inflammatory Agents; Azathioprine; Calcineurin Inhibitors; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Humans; Immunosuppressive Agents; Infusions, Intravenous; Mesalamine; Proctocolectomy, Restorative; Remission Induction; Secondary Prevention; Tumor Necrosis Factor-alpha | 2012 |
Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Infliximab; Treatment Failure; Treatment Outcome | 2013 |
Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis.
Topics: Acute Disease; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Infliximab; Postoperative Complications; Publication Bias; Steroids | 2013 |
Ulcerative colitis.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Biological Products; Breast Feeding; Colectomy; Colitis, Ulcerative; Colorectal Neoplasms; Cyclosporine; Early Detection of Cancer; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Osteoporosis; Patient Education as Topic; Pregnancy; Pregnancy Complications; Remission Induction; Thionucleosides; Tumor Necrosis Factor-alpha | 2013 |
Immunosuppressants and operation in ulcerative colitis.
Topics: Azathioprine; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Mercaptopurine; Proctocolectomy, Restorative | 2002 |
Evolving medical therapies for ulcerative colitis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antineoplastic Agents; Budesonide; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Interferons; Mesalamine; Treatment Outcome | 2002 |
Recent developments in inflammatory bowel disease.
Topics: Adjuvants, Immunologic; Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Glucocorticoids; Humans; Infliximab; Mercaptopurine; Sulfasalazine; Tumor Necrosis Factor-alpha | 2002 |
Ciclosporin and refractory colitis.
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents | 2003 |
[Medical management of inflammatory bowel disease: consensus and controversies].
Topics: Acute Disease; Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Parenteral Nutrition; Preoperative Care | 2003 |
The state of the art in the management of inflammatory bowel disease.
Topics: Administration, Oral; Adrenal Cortex Hormones; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Intestinal Mucosa; Long-Term Care; Male; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2003 |
Review article: medical treatment of severe ulcerative colitis.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Treatment Outcome | 2003 |
Medical management of ulcerative colitis.
Topics: Acute Disease; Administration, Oral; Aminosalicylic Acids; Anti-Bacterial Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Colonic Neoplasms; Cyclosporine; Epidermal Growth Factor; Gastrointestinal Agents; Heparin; Humans; Infliximab; Probiotics; Purines; Risk Factors; Steroids | 2003 |
Medical therapy for ulcerative colitis 2004.
Topics: Adjuvants, Immunologic; Aminosalicylic Acids; Antimetabolites; Biological Therapy; Chemoprevention; Colectomy; Colitis, Ulcerative; Cyclosporine; Glucocorticoids; Humans | 2004 |
Medical management of severe ulcerative colitis.
Topics: Adrenal Cortex Hormones; Azathioprine; Colitis, Ulcerative; Cyclosporine; Decision Trees; Drug Administration Schedule; Humans; Immunosuppressive Agents; Mercaptopurine; Severity of Illness Index | 2004 |
How effective are the usual treatments for ulcerative colitis?
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Cyclosporine; Humans; Randomized Controlled Trials as Topic | 2004 |
Drug therapy for ulcerative colitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Medicine, Chinese Traditional; Mercaptopurine | 2004 |
Medical therapy for ulcerative colitis: the state of the art and beyond.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Butyrates; Colitis, Ulcerative; Cyclosporine; Epidermal Growth Factor; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Interferons; Mercaptopurine; Plasmapheresis; Probiotics; Remission Induction; Thiazoles | 2004 |
Cyclosporine A for induction of remission in severe ulcerative colitis.
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Randomized Controlled Trials as Topic; Remission Induction | 2005 |
[Immunosuppressants for therapy of patients with ulcerative colitis].
Topics: Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Guanine Nucleotides; Humans; Immunosuppressive Agents; Mercaptopurine; Methyltransferases; Mycophenolic Acid; Tacrolimus; Thionucleotides | 2005 |
[New therapies for inflammatory bowel disease].
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Cytapheresis; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Male; Tacrolimus | 2005 |
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; CD28 Antigens; Colitis, Ulcerative; Cyclosporine; Cytokines; Dermatomyositis; Humans; Immune Tolerance; Immunosuppressive Agents; Inflammation; Lupus Erythematosus, Systemic; T-Lymphocytes | 2005 |
Review article: how and when to use ciclosporin in ulcerative colitis.
Topics: Administration, Oral; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Injections, Intravenous | 2005 |
Cyclosporine for severe ulcerative colitis.
Topics: Colitis, Ulcerative; Cyclosporine; Drug Information Services; Humans; Immunosuppressive Agents; Injections, Intravenous; Randomized Controlled Trials as Topic; Severity of Illness Index | 2006 |
Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review.
Topics: Administration, Oral; Adrenal Cortex Hormones; Azathioprine; Clinical Trials as Topic; Colitis, Ulcerative; Controlled Clinical Trials as Topic; Cyclosporine; Disease Susceptibility; Drug Resistance; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infections; Infusions, Intravenous; Research Design; Seizures; Treatment Outcome | 2005 |
[Treatment of servere ulcerative colitis].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Patient Care Management; Remission Induction | 2006 |
Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?
Topics: Adrenal Cortex Hormones; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Evidence-Based Medicine; Humans; Immune Tolerance; Immunosuppressive Agents; Randomized Controlled Trials as Topic | 2006 |
Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression.
Topics: Adrenal Cortex Hormones; Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Methylprednisolone; Severity of Illness Index | 2007 |
Current management of severe ulcerative colitis.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Prognosis; Severity of Illness Index; Treatment Outcome | 2007 |
[Anti-TNF-alpha antibody treatment of patients with active ulcerative colitis].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Treatment Outcome | 2007 |
[Management of severe or corticosteroid resistant ulcerative colitis].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antiviral Agents; Colectomy; Colitis, Ulcerative; Cyclosporine; Cytomegalovirus Infections; Drug Resistance; Foscarnet; Ganciclovir; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Multicenter Studies as Topic; Prospective Studies; Radionuclide Imaging; Randomized Controlled Trials as Topic; Time Factors | 2007 |
[Medical therapy of inflammatory bowel diseases: ulcerative colitis].
Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Carcinoma; Colitis, Ulcerative; Colorectal Neoplasms; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Severity of Illness Index | 2007 |
[Inflammatory bowel disease: current progress and future aspect].
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Forecasting; Humans; Immunotherapy; Inflammatory Bowel Diseases; Infliximab; Leukapheresis; Point Mutation; T-Lymphocytes, Cytotoxic | 2007 |
[Current status of treatment of inflammatory bowel disease].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Certolizumab Pegol; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colectomy; Colitis, Ulcerative; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Infusions, Intravenous; Mercaptopurine; Meta-Analysis as Topic; Polyethylene Glycols; Quality of Life; Rectal Fistula; Recurrence; Time Factors | 2007 |
Medical treatment of ulcerative colitis.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Colitis; Colitis, Ulcerative; Cyclosporine; Disease Progression; Humans; Immunologic Factors; Infliximab; Recurrence; Remission Induction | 2007 |
Severe ulcerative colitis: present medical treatment strategies.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Injections, Intravenous | 2008 |
Treatment of choice for acute severe steroid-refractory ulcerative colitis is cyclosporine.
Topics: Acute Disease; Clinical Trials as Topic; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Glucocorticoids; Humans; Immunosuppressive Agents | 2009 |
Review article: evolving concepts in treatment and disease modification in ulcerative colitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biological Therapy; Colitis, Ulcerative; Cyclosporine; Forecasting; Humans; Immunosuppressive Agents; Mesalamine; Patient Satisfaction | 2008 |
Optimizing drug therapy in inflammatory bowel disease.
Topics: Absorptiometry, Photon; Adalimumab; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Cyclosporine; Humans; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Mesalamine; Patient Compliance; Prednisone; Treatment Failure | 2007 |
Value of colonoscopy for prediction of prognosis in patients with ulcerative colitis.
Topics: Colitis, Ulcerative; Colonoscopy; Cyclosporine; Endoscopy; Gastroenterology; Humans; Leukocytes; Microscopy, Confocal; Prognosis; Recurrence; Time Factors; Treatment Outcome | 2008 |
[Cyclosporine A and chronic inflammatory diseases of the digestive tract].
Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Inflammatory Bowel Diseases | 1995 |
Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; History, 20th Century; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications | 1995 |
Cyclosporine: indications and use in gastrointestinal diseases.
Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Gastrointestinal Diseases; Humans; Immunosuppression Therapy | 1995 |
[Current medical treatment of hemorrhagic rectocolitis].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Mesalamine; Sulfasalazine | 1994 |
Medical therapy for ulcerative colitis in childhood.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Child; Child, Preschool; Clinical Trials as Topic; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Humans; Infant; Intestinal Mucosa; Mercaptopurine; Mesalamine; Sulfasalazine | 1994 |
Medical management of patients with difficult-to-treat inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole | 1994 |
Cyclosporine therapy for gastrointestinal disease.
Topics: Autoimmune Diseases; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Gastrointestinal Diseases; Humans; Intestinal Diseases | 1994 |
Parastomal pyoderma gangrenosum in inflammatory bowel disease.
Topics: Adult; Colitis, Ulcerative; Colostomy; Combined Modality Therapy; Crohn Disease; Curettage; Cyclosporine; Female; Humans; Male; Middle Aged; Proctitis; Pyoderma Gangrenosum; Retrospective Studies; Steroids; Treatment Outcome; Wound Healing | 1994 |
Cyclosporin for inflammatory bowel disease: mechanisms and possible actions.
Topics: Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Administration Routes; Humans; Inflammatory Bowel Diseases; Kidney; Lymphocyte Activation; T-Lymphocytes; Time Factors | 1993 |
Clinical pharmacology in gastroenterology: development of new forms of treatment of inflammatory bowel disease.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Delayed-Action Preparations; Denmark; History, 20th Century; Humans; Immunosuppressive Agents; Mesalamine | 1996 |
Selective immunomodulation in patients with inflammatory bowel disease--future therapy or reality?
Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Cytokines; Humans; Immunosuppressive Agents; Immunotherapy; Inflammatory Bowel Diseases; Intestinal Mucosa | 1996 |
Newer treatments for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Nutritional Physiological Phenomena | 1996 |
[Treatment of acute a steroid-resistant ulcerative colitis with continuous venous infusion of cyclosporine].
Topics: Acute Disease; Adolescent; Adult; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged | 1996 |
The modern medical management of acute, severe ulcerative colitis.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Colectomy; Colitis, Ulcerative; Contraindications; Cyclosporine; Heparin; Humans; Immunosuppressive Agents; Megacolon, Toxic; Mercaptopurine; Prognosis; Treatment Outcome | 1997 |
Immunosuppressive treatment for refractory ulcerative colitis--where do we stand and where are we going?
Topics: Azathioprine; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Interleukin-10; Mercaptopurine; Methotrexate | 1997 |
Drug therapy for ulcerative colitis during pregnancy.
Topics: Adrenal Cortex Hormones; Antidiarrheals; Azathioprine; Breast Feeding; Colitis, Ulcerative; Cyclosporine; Female; Humans; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications; Sulfasalazine | 1997 |
Inflammatory bowel disease.
Topics: Abdomen, Acute; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Diagnosis, Differential; Emergencies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Perforation; Megacolon, Toxic; Prognosis; Survival Rate | 1997 |
Management of severe colitis/ileocolitis.
Topics: Azathioprine; Child; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Humans; Immunosuppressive Agents; Remission Induction; Severity of Illness Index | 1998 |
Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.
Topics: Adolescent; Adult; Cholangitis, Sclerosing; Colitis, Ulcerative; Cyclosporine; Female; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Precancerous Conditions; Risk Factors; Tacrolimus | 1998 |
Medical therapy for inflammatory bowel disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Recurrence; Salicylates; Severity of Illness Index; Steroids | 1999 |
[Pyoderma gangrenosum with an atypical location and a rapid response to cyclosporin A].
Topics: Administration, Oral; Adult; Colitis, Ulcerative; Cyclosporine; Dermatologic Agents; Female; Forehead; Hand Dermatoses; Humans; Pyoderma Gangrenosum | 1999 |
New strategies in the management of inflammatory bowel disease.
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Glucocorticoids; Humans; Immunity, Mucosal; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Prevalence; Tumor Necrosis Factor-alpha | 1999 |
[Immunosuppressive treatment of ulcerative colitis].
Topics: Azathioprine; Colitis, Ulcerative; Cyclosporine; Cytokines; Depression, Chemical; Humans; Immunosuppressive Agents; Mercaptopurine; Tacrolimus | 1999 |
[Therapeutic strategy for severe and fulminating ulcerative colitis].
Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infusions, Intra-Arterial; Infusions, Intravenous; Leukapheresis; Metronidazole; Prednisolone; Severity of Illness Index | 1999 |
[Recent progress in therapy of inflammatory bowel diseases].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Enteral Nutrition; Humans; Immunoglobulins, Intravenous; Leukapheresis; Mesalamine; Methotrexate; Receptors, Glucocorticoid; Steroids | 1999 |
[Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy; Colitis, Ulcerative; Colon; Crohn Disease; Cyclosporine; Humans; Hydroxyurea; Ileum; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Microscopy; Sulfasalazine; Time Factors | 1999 |
Clinical evaluation and management of acute severe colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Bacterial Agents; Colitis, Ulcerative; Cyclosporine; Diagnosis, Differential; Humans; Ileostomy; Immunosuppressive Agents; Life Style; Prognosis; Severity of Illness Index; Tacrolimus | 2000 |
Medical management of fulminant colitis.
Topics: Acute Disease; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Decision Trees; Humans; Severity of Illness Index | 2002 |
Review article: Immunosuppressants in distal ulcerative colitis.
Topics: Adult; Aged; Azathioprine; Colitis, Ulcerative; Cyclosporine; Databases, Factual; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Middle Aged; Treatment Outcome | 2002 |
Review article: medical treatment of severe ulcerative colitis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Prognosis; Retrospective Studies; Severity of Illness Index; Steroids | 2002 |
Cyclosporine treatment of inflammatory bowel disease.
Topics: Cholangitis, Sclerosing; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Hypertrichosis; Kidney Diseases; Paresthesia; Proctocolitis | 1992 |
[Therapeutic alternatives in Crohn disease and in ulcero-hemorrhagic rectocolitis: current findings].
Topics: Antineoplastic Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Methotrexate | 1992 |
Cyclosporin in inflammatory bowel disease.
Topics: Animals; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Inflammatory Bowel Diseases | 1991 |
The role of ciclosporin therapy in Crohn's disease. A review.
Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Enema; Humans; Prednisolone | 1991 |
The management of acute severe ulcerative colitis.
Topics: Acute Disease; Colectomy; Colitis, Ulcerative; Cyclosporine; Fluid Therapy; Humans; Hydrocortisone; Methylprednisolone | 1991 |
33 trial(s) available for cyclosporine and Colitis Gravis
Article | Year |
---|---|
A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab.
Topics: Antibodies, Monoclonal, Humanized; C-Reactive Protein; Colitis, Ulcerative; Cyclosporine; Follow-Up Studies; Gastrointestinal Agents; Humans; Induction Chemotherapy; Leukocyte L1 Antigen Complex; Prospective Studies; Remission Induction; Steroids; Treatment Outcome | 2022 |
Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial.
Topics: Colitis, Ulcerative; Cost-Benefit Analysis; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Quality-Adjusted Life Years; Steroids | 2023 |
Patient views about the impact of ulcerative colitis and its management with drug treatment and surgery: a nested qualitative study within the CONSTRUCT trial.
Topics: Adaptation, Psychological; Colitis, Ulcerative; Cyclosporine; Diarrhea; Embarrassment; Fatigue; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Qualitative Research; Quality of Life; Social Stigma | 2019 |
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine.
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Infliximab; Prospective Studies; Severity of Illness Index; Steroids; Treatment Outcome | 2021 |
High Remission Rate with Infliximab and Plant-Based Diet as First-Line (IPF) Therapy for Severe Ulcerative Colitis: Single-Group Trial.
Topics: Colectomy; Colitis, Ulcerative; Cyclosporine; Diet, Vegetarian; Humans; Infliximab; Retrospective Studies; Treatment Outcome | 2020 |
Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT).
Topics: Adrenal Cortex Hormones; Colectomy; Colitis, Ulcerative; Cost-Benefit Analysis; Cyclosporine; Disease Progression; Drug Costs; Drug Resistance; Humans; Immunosuppressive Agents; Infliximab; Quality of Life; Quality-Adjusted Life Years; United Kingdom | 2014 |
IBD. Sequential rescue therapy in steroid-refractory ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Humans; Immunosuppressive Agents; Infliximab; Steroids; Tacrolimus | 2014 |
Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: pragmatic randomised Trial and economic evaluation (CONSTRUCT).
Topics: Adult; Colitis, Ulcerative; Cost-Benefit Analysis; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Models, Econometric; Quality of Life; Quality-Adjusted Life Years; State Medicine; United Kingdom | 2016 |
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Colitis, Ulcerative; Cost-Benefit Analysis; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hydrocortisone; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; United Kingdom; Young Adult | 2016 |
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.
Topics: Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Disease-Free Survival; Drug Resistance; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Steroids; Time Factors; Treatment Outcome | 2018 |
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Male; Middle Aged; Steroids; Treatment Failure | 2012 |
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis.
Topics: Acute Disease; Adult; Colitis, Ulcerative; Cyclosporine; Double-Blind Method; Endoscopy, Digestive System; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Severity of Illness Index; Treatment Outcome | 2003 |
Combination immunomodulatory therapy with cyclosporine and azathioprine in corticosteroid-resistant severe ulcerative colitis: the Edinburgh experience of outcome.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Injections, Intravenous; Male; Methylprednisolone; Pneumocystis Infections; Prednisolone; Salvage Therapy; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
Intravenous cyclosporine in severe ulcerative colitis: how low can you go?
Topics: Colitis, Ulcerative; Colonoscopy; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2004 |
Efficacy of intravenous cyclosporin in moderately severe ulcerative colitis refractory to steroids.
Topics: Administration, Oral; Adolescent; Adult; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Proctocolectomy, Restorative; Remission Induction; Treatment Outcome | 2005 |
Low-dose oral microemulsion ciclosporin for severe, refractory ulcerative colitis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; C-Reactive Protein; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Emulsions; Humans; Immunosuppressive Agents; Microchemistry; Middle Aged; Severity of Illness Index; Treatment Failure | 2005 |
Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Basiliximab; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Prednisolone; Quality of Life; Receptors, Interleukin-2; Recombinant Fusion Proteins; Severity of Illness Index; Treatment Outcome | 2006 |
Treatment of ulcerative colitis refractory to steroid therapy by oral microemulsion cyclosporine (Neoral).
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Emulsions; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Remission Induction; Treatment Outcome | 2006 |
A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Cyclosporine; Enema; Female; Humans; Mesalamine; Middle Aged; Placebos; Salicylates | 1994 |
Cyclosporine in severe ulcerative colitis refractory to steroid therapy.
Topics: Adolescent; Adult; Aged; Colectomy; Colitis, Ulcerative; Cyclosporine; Double-Blind Method; Female; Humans; Hydrocortisone; Infusions, Intravenous; Male; Middle Aged; Monitoring, Physiologic | 1994 |
Cyclosporin A retention enemas in refractory distal ulcerative colitis and 'pouchitis'.
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Enema; Female; Humans; Inflammation; Male; Postoperative Complications; Proctocolectomy, Restorative; Sigmoidoscopy | 1993 |
Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin.
Topics: Adult; Cholangitis, Sclerosing; Colitis, Ulcerative; Colon; Cyclosporine; Double-Blind Method; Female; Humans; Male; Middle Aged | 1993 |
Cyclosporine enemas for treatment-resistant, mildly to moderately active, left-sided ulcerative colitis.
Topics: Administration, Topical; Chromatography, High Pressure Liquid; Colitis, Ulcerative; Colon; Cyclosporine; Enema; Female; Humans; Male; Middle Aged; Time Factors | 1993 |
Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Inflammatory Bowel Diseases; Male; Mercaptopurine; Remission Induction; Treatment Outcome | 1996 |
Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses.
Topics: Adolescent; Adult; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 1996 |
[Treatment of acute a steroid-resistant ulcerative colitis with continuous venous infusion of cyclosporine].
Topics: Acute Disease; Adolescent; Adult; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged | 1996 |
Cyclosporin for severe ulcerative colitis: a user's guide.
Topics: Administration, Oral; Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclosporine; Drug Monitoring; Follow-Up Studies; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Longitudinal Studies; Middle Aged; Monitoring, Ambulatory; Prednisone; Treatment Outcome | 1997 |
Intravenous cyclosporine for severe attacks of ulcerative colitis: a survey of Canadian gastroenterologists.
Topics: Adult; Canada; Colitis, Ulcerative; Cyclosporine; Gastroenterology; Health Care Surveys; Humans; Immunosuppressive Agents; Injections, Intravenous; Middle Aged; Safety; Societies, Medical; Surveys and Questionnaires | 1997 |
Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis.
Topics: Colitis, Ulcerative; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Time Factors; Treatment Outcome | 1998 |
Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Capsules; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Drug Resistance; Emulsions; Female; Follow-Up Studies; Humans; Hydrocortisone; Immunosuppressive Agents; Injections, Intravenous; Intestinal Absorption; Male; Middle Aged; Prognosis; Treatment Outcome | 1998 |
A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin.
Topics: Adult; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Data Collection; Female; Health Services; Hospitalization; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Patient Satisfaction; Prognosis; Quality of Life; Severity of Illness Index; Statistics, Nonparametric; Surveys and Questionnaires; United States | 1999 |
[Cyclosporin in an oral microemulsion as the initial treatment of corticoid-refractory ulcerative colitis].
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Emulsions; Female; Humans; Immunosuppressive Agents; Male | 2000 |
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis.
Topics: Adult; Aged; Colectomy; Colitis, Ulcerative; Cyclosporine; Double-Blind Method; Endoscopy, Gastrointestinal; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney; Male; Methylprednisolone; Middle Aged; Prospective Studies; Radionuclide Imaging | 2001 |
290 other study(ies) available for cyclosporine and Colitis Gravis
Article | Year |
---|---|
Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis.
Topics: Calcineurin Inhibitors; Colitis, Ulcerative; Cyclosporine; Humans; Immunologic Factors; Induction Chemotherapy; Infliximab; Retrospective Studies; Treatment Outcome; Ustekinumab | 2023 |
Cyclosporine Therapy as a Rescue Treatment in Steroid Refractory Acute Severe Ulcerative Colitis: A Real Life Data From a Tertiary Center.
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Steroids | 2022 |
An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis.
Topics: Biological Factors; Biological Products; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Infliximab | 2022 |
Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response.
Topics: Adrenal Cortex Hormones; Adult; Albumins; Biological Products; C-Reactive Protein; Colectomy; Colitis; Colitis, Ulcerative; Cyclosporine; Humans; Prognosis; Retrospective Studies; Severity of Illness Index; Steroids; Treatment Outcome | 2023 |
Long-term outcomes of patients with acute severe ulcerative colitis treated with cyclosporine rescue therapy.
Topics: Adrenal Cortex Hormones; Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Retrospective Studies; Treatment Outcome | 2023 |
A topical thermosensitive hydrogel system with cyclosporine A PEG-PCL micelles alleviates ulcerative colitis induced by TNBS in mice.
Topics: Animals; Colitis; Colitis, Ulcerative; Cyclosporine; Cytokines; Hydrogels; Mice; Micelles; Poloxamer | 2023 |
Cyclosporine A-loaded colon-targeted oral nanomicelles self-assembly by galactosylated carboxymethyl chitosan for efficient ulcerative colitis therapy.
Topics: Animals; Chitosan; Colitis, Ulcerative; Cyclosporine; Dextran Sulfate; Mice; Nanoparticles; Polymers | 2023 |
A PepT1 mediated medicinal nano-system for targeted delivery of cyclosporine A to alleviate acute severe ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Colon; Cyclosporine; Dextran Sulfate; Drug Carriers; Male; Mice, Inbred BALB C; Nanoparticles; Oligopeptides; Peptide Transporter 1; Polylactic Acid-Polyglycolic Acid Copolymer | 2019 |
Health-Related Quality of Life in Patients with Moderate to Severe Ulcerative Colitis: Surgical Intervention versus Immunomodulatory Therapy.
Topics: Adult; Azathioprine; Colitis, Ulcerative; Colon; Cross-Sectional Studies; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunologic Factors; Infliximab; Male; Middle Aged; Postoperative Complications; Pouchitis; Quality of Life; Retrospective Studies; Severity of Illness Index | 2020 |
A Long-Term Follow-up of Retinal Vasculitis - Do They Develop Systemic Disease?
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Retinal Vasculitis; Retrospective Studies; Tuberculin Test; Tuberculosis, Ocular; Visual Acuity; Vitreous Hemorrhage | 2020 |
[Three cases of severe and fulminating ulcerative colitis with megacolon treated with continuous intravenous infusion of cyclosporine].
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infusions, Intravenous; Megacolon; Megacolon, Toxic | 2020 |
Letter: ciclosporin and vedolizumab for steroid-refractory ulcerative colitis.
Topics: Antibodies, Monoclonal, Humanized; Calcineurin Inhibitors; Colitis, Ulcerative; Cyclosporine; Humans | 2020 |
Amelioration of murine experimental colitis using biocompatible cyclosporine A lipid carriers.
Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Cyclosporine; Lipids; Mice | 2021 |
Dextran sulfate sodium-induced colitis and ginseng intervention altered oral pharmacokinetics of cyclosporine A in rats.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Colitis, Ulcerative; Cyclosporine; Cytochrome P-450 CYP3A; Dextran Sulfate; Disease Models, Animal; Herb-Drug Interactions; Humans; Immunosuppressive Agents; Intestinal Mucosa; Liver; Male; Panax; Plant Extracts; Rats; Rats, Sprague-Dawley | 2021 |
Letter: long-term outcomes of patients with acute severe ulcerative colitis after intravenous steroid therapy.
Topics: Administration, Intravenous; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Steroids | 2020 |
Long-term outcome of patients with acute ulcerative colitis after first course of intravenous corticosteroids.
Topics: Adrenal Cortex Hormones; Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Retrospective Studies; Treatment Outcome | 2021 |
A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease.
Topics: Adult; Colectomy; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Emergency Service, Hospital; Female; Hospitalization; Humans; Hypoalbuminemia; Hypotension; Immunosuppressive Agents; Infliximab; Length of Stay; Male; Middle Aged; Salvage Therapy; Severity of Illness Index; Symptom Flare Up; Tachycardia; Tumor Necrosis Factor Inhibitors | 2022 |
Cyclosporine modulates neutrophil functions via the SIRT6-HIF-1α-glycolysis axis to alleviate severe ulcerative colitis.
Topics: Adult; Aged; Apoptosis; Colitis, Ulcerative; Cyclosporine; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunosuppressive Agents; Male; Middle Aged; Neutrophils; Polymerase Chain Reaction; Sirtuins; Young Adult | 2021 |
Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis.
Topics: Colectomy; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Retrospective Studies; Steroids; Treatment Outcome | 2021 |
Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis.
Topics: Acute Disease; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Severity of Illness Index; Steroids; Treatment Outcome | 2021 |
Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine.
Topics: Antibodies, Monoclonal, Humanized; Child; Colitis, Ulcerative; Cyclosporine; Humans; Pyoderma Gangrenosum | 2021 |
Response to the Letter to the Editor: "Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine".
Topics: Antibodies, Monoclonal, Humanized; Child; Colitis, Ulcerative; Cyclosporine; Humans; Pyoderma Gangrenosum | 2021 |
Rescue therapy with oral cyclosporine after use of ustekinumab in ulcerative colitis resistant to multiple treatments.
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Treatment Outcome; Ustekinumab | 2022 |
Targeting of the Tec Kinase ITK Drives Resolution of T Cell-Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative Colitis.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cells, Cultured; Colitis, Ulcerative; Colon; Cyclosporine; Cytokines; Disease Models, Animal; Humans; Intestinal Mucosa; Intraepithelial Lymphocytes; Mice, Knockout; Molecular Targeted Therapy; Phosphorylation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Signal Transduction | 2021 |
Success of Cyclosporin and Tofacitinib Combination Therapy in a Patient With Severe Steroid-refractory Ulcerative Colitis.
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Piperidines; Pyrimidines; Steroids | 2021 |
Healthcare professionals' views of the use and administration of two salvage therapy drugs for acute ulcerative colitis: a nested qualitative study within the CONSTRUCT trial.
Topics: Attitude of Health Personnel; Colitis, Ulcerative; Cyclosporine; Humans; Infliximab; Interviews as Topic; Medication Therapy Management; National Health Programs; Pragmatic Clinical Trials as Topic; Qualitative Research; Salvage Therapy; United Kingdom | 2017 |
Infliximab or ciclosporin for acute severe ulcerative colitis?
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab | 2016 |
The Effective Treatment with Cyclosporine of a Ulcerative Colitis Patient with Concurrent Idiopathic Thrombocytopenic Purpura Who Subsequently Developed Spontaneous Pneumomediastinum.
Topics: Adolescent; Colitis, Ulcerative; Cyclosporine; Humans; Male; Mediastinal Emphysema; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome | 2017 |
Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.
Topics: Adult; Antiviral Agents; Colectomy; Colitis, Ulcerative; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Retrospective Studies; Risk Factors; Salvage Therapy; Young Adult | 2017 |
Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infections; Infliximab; Male; Middle Aged; Mortality; Registries; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
Self-assembling polymeric nanocarriers to target inflammatory lesions in ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Colon; Cyclosporine; Drug Carriers; Immunosuppressive Agents; Male; Mice, Inbred C57BL; Nanoparticles; Polymers; Trinitrobenzenesulfonic Acid | 2018 |
Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis.
Topics: Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Prospective Studies; Registries; Retrospective Studies | 2017 |
Cyclosporine for severe steroid-refractory ulcerative colitis: commenting the comment.
Topics: Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab | 2018 |
Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
Topics: Acute Kidney Injury; Adult; C-Reactive Protein; Chicago; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Postoperative Complications; Prednisolone; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2018 |
Salvage therapy for acute severe ulcerative colitis during pregnancy.
Topics: Adult; Cesarean Section; Colectomy; Colitis, Ulcerative; Cyclosporine; Diagnosis, Differential; Female; Gastrointestinal Agents; HELLP Syndrome; Humans; Hydrocortisone; Immunosuppressive Agents; Infliximab; Laparoscopy; Pregnancy; Salvage Therapy; Severity of Illness Index; Treatment Outcome | 2018 |
What is causing this patient's multiple skin abscesses?
Topics: Abscess; Adolescent; Colitis, Ulcerative; Cyclosporine; Dermatologic Agents; Female; Gastrointestinal Agents; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Infliximab; Metronidazole; Physician Assistants; Pyoderma Gangrenosum; Skin Diseases, Infectious | 2018 |
Superficial granulomatous pyoderma in a patient with ulcerative colitis successfully treated with cyclosporine A.
Topics: Biopsy; Clobetasol; Colitis, Ulcerative; Cyclosporine; Debridement; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Leg; Middle Aged; Pyoderma Gangrenosum; Skin; Treatment Outcome | 2019 |
Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
Topics: Acute Disease; Adult; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Male; Retrospective Studies; Treatment Failure; Treatment Outcome; Young Adult | 2019 |
Acute Severe Ulcerative Colitis: The Oxford Criteria No Longer Predict In-Hospital Colectomy Rates.
Topics: Acute Disease; Administration, Intravenous; Adult; C-Reactive Protein; Colectomy; Colitis, Ulcerative; Cyclosporine; Defecation; Female; Gastrointestinal Agents; Glucocorticoids; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2020 |
Letter: factors that may predict response to ciclosporin in ulcerative colitis.
Topics: Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male | 2013 |
Letter: factors that may predict response to ciclosporin in ulcerative colitis - authors' reply.
Topics: Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male | 2013 |
High TPMT activity as a risk factor for severe myelosuppression during thiopurine therapy.
Topics: Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methyltransferases; Pancytopenia; Risk Factors | 2013 |
Rescue therapy: ciclosporin or infliximab?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Steroids | 2013 |
Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.
Topics: Adult; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Prospective Studies; Salvage Therapy; Treatment Outcome | 2013 |
Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit.
Topics: Adult; Aged; Aged, 80 and over; Clinical Audit; Cohort Studies; Colitis, Ulcerative; Cyclosporine; Female; Hospital Mortality; Hospitalization; Humans; Immunosuppressive Agents; Male; Middle Aged; Steroids; Treatment Outcome; Tumor Necrosis Factor-alpha; United Kingdom | 2013 |
Commentary: salvage medical therapy for acute severe colitis - ciclosporin or infliximab?
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Male; Salvage Therapy | 2013 |
Commentary: salvage medical therapy for acute severe colitis - ciclosporin or infliximab? Author's reply.
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Male; Salvage Therapy | 2013 |
Letter: ciclosporin or infliximab in acute ulcerative colitis - still undecided.
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Male; Salvage Therapy | 2013 |
Letter: ciclosporin or infliximab in acute ulcerative colitis - still undecided; authors' reply.
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Male; Salvage Therapy | 2013 |
Long-term increase in serum cholesterol levels in ulcerative colitis patients treated with cyclosporine: an underdiagnosed side effect frequently associated with other drug-related complications.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Cholesterol; Colitis, Ulcerative; Creatinine; Cyclosporine; Female; Humans; Hypercholesterolemia; Hypertension; Hypertrichosis; Hypertriglyceridemia; Hypesthesia; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Myalgia; Prospective Studies; Time Factors; Tremor; Young Adult | 2014 |
Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Gastrointestinal Agents; Glucocorticoids; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Postoperative Complications; Prognosis; Retrospective Studies; Risk Factors; Salvage Therapy; Young Adult | 2014 |
Letter: acute severe ulcerative colitis - should all patients be treated equally?
Topics: Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Steroids; Tumor Necrosis Factor-alpha | 2014 |
Letter: acute severe ulcerative colitis - should all patients be treated equally? Authors' reply.
Topics: Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Steroids; Tumor Necrosis Factor-alpha | 2014 |
[Acute pericarditis associated with oral or topical mesalazine therapy in patients with ulcerative colitis].
Topics: Administration, Oral; Administration, Rectal; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chest Pain; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Humans; Ileostomy; Male; Mesalamine; Pericarditis; Postoperative Complications; Suppositories | 2014 |
[Ciclosporin or infliximab for severe steroid refractory ulcerative colitis: GETAID study (Group d'Etudes Thérapeutiques des Affections Inflammatoires Digestives)].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Steroids | 2014 |
Downregulation of CYP3A and P-glycoprotein in the secondary inflammatory response of mice with dextran sulfate sodium-induced colitis and its contribution to cyclosporine A blood concentrations.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Colitis, Ulcerative; Cyclosporine; Cytochrome P-450 CYP3A; Dextran Sulfate; Down-Regulation; Humans; Intestine, Small; Liver; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Pregnane X Receptor; Receptors, Steroid | 2014 |
Risk of colectomy in patients with ulcerative colitis under thiopurine treatment.
Topics: Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Mercaptopurine; Probability; Risk Factors; Severity of Illness Index; Spain; Tumor Necrosis Factor-alpha; Young Adult | 2014 |
The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Retreatment; Retrospective Studies; Salvage Therapy; Severity of Illness Index; Steroids; Tacrolimus; Treatment Failure; Young Adult | 2014 |
Long-term comparative efficacy of cyclosporine- or infliximab-based strategies for the management of steroid-refractory ulcerative colitis attacks.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Disease Management; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gastrointestinal Agents; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Prognosis | 2014 |
Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Male; Methylprednisolone; Middle Aged; Prednisone; Retreatment; Retrospective Studies; Severity of Illness Index; Treatment Failure | 2014 |
Cyclosporine A regulates pro-inflammatory cytokine production in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Apoptosis; Case-Control Studies; Caspase 8; CD4-Positive T-Lymphocytes; Cell Survival; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Cytokines; Flow Cytometry; Gene Expression Regulation; Humans; Inflammation; Interleukin-13; Leukocytes, Mononuclear; Microscopy, Fluorescence; Middle Aged; T-Lymphocytes; Young Adult | 2015 |
Length of hospital stay and associated hospital costs with infliximab versus cyclosporine in severe ulcerative colitis.
Topics: Adult; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Costs; Female; Gastrointestinal Agents; Health Services Research; Hospital Costs; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Kaplan-Meier Estimate; Length of Stay; Male; Netherlands; Treatment Outcome; Young Adult | 2014 |
Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult | 2015 |
Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Child; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2015 |
Algorithm for managing severe ulcerative colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Algorithms; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Counseling; Cyclosporine; Emergencies; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Monitoring, Physiologic; Nutritional Support; Remission Induction; Tacrolimus | 2014 |
Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Female; Follow-Up Studies; Humans; Hydrocortisone; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Prognosis; Retreatment; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2015 |
Co-administration of α-lipoic acid and cyclosporine aggravates colon ulceration of acetic acid-induced ulcerative colitis via facilitation of NO/COX-2/miR-210 cascade.
Topics: Acetic Acid; Animals; C-Reactive Protein; Catalase; Colitis, Ulcerative; Colon; Cyclooxygenase 2; Cyclosporine; Dose-Response Relationship, Drug; Glutathione; Male; Malondialdehyde; MicroRNAs; Nitric Oxide; Rats; Rats, Wistar; Superoxide Dismutase; Thioctic Acid; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2015 |
Does the Cyclosporine Still Have a Potential Role in the Treatment of Acute Severe Steroid-Refractory Ulcerative Colitis?
Topics: Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Salvage Therapy | 2015 |
Has widespread use of biologic and immunosuppressant therapy for ulcerative colitis affected surgical trends? Results of a questionnaire survey of surgical institutions in Japan.
Topics: Biological Factors; Colitis, Ulcerative; Cyclosporine; Digestive System Surgical Procedures; Hospitals, Teaching; Humans; Immunosuppressive Agents; Infliximab; Japan; Postoperative Complications; Risk; Surgery Department, Hospital; Surveys and Questionnaires; Tacrolimus; Time Factors | 2016 |
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha | 2015 |
Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients.
Topics: Adrenal Cortex Hormones; Adult; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Female; Follow-Up Studies; Hospitalization; Humans; Induction Chemotherapy; Infliximab; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Treatment Failure; Treatment Outcome | 2016 |
Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies.
Topics: Administration, Intravenous; Adrenal Cortex Hormones; Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Spain; Tertiary Care Centers; Treatment Failure | 2016 |
Endoscopic and histologic response to cyclosporine in ulcerative colitis and their impact on disease outcome: A cohort study.
Topics: Acute Disease; Administration, Intravenous; Adolescent; Adult; Aged; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Female; France; Humans; Immunosuppressive Agents; Intestinal Mucosa; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Severity of Illness Index; Young Adult | 2016 |
Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Enteral Nutrition; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Longitudinal Studies; Male; Mesalamine; Retrospective Studies | 2016 |
Bilateral lower limb weakness in acute severe ulcerative colitis.
Topics: Colitis, Ulcerative; Cyclosporine; Epidural Space; Glucocorticoids; Humans; Immunosuppressive Agents; Lipomatosis; Lower Extremity; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Weakness; Obesity; Prednisolone; Spinal Cord Compression; Thoracic Vertebrae | 2016 |
Outcome of acute severe ulcerative colitis in patients previously exposed to immunosuppressive therapy.
Topics: Acute Disease; Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Disease-Free Survival; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Steroids; Treatment Outcome; Young Adult | 2016 |
There is Significant Practice Pattern Variability in the Management of the Hospitalized Ulcerative Colitis Patient at a Tertiary Care and IBD Referral Center.
Topics: Adult; Colectomy; Colitis, Ulcerative; Critical Pathways; Cyclosporine; Decision Support Techniques; Female; Humans; Immunosuppressive Agents; Infliximab; Male; New York City; Patient Admission; Practice Patterns, Physicians'; Surveys and Questionnaires; Tertiary Care Centers | 2018 |
Medical treatment and management of severe ulcerative colitis.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Humans; Infliximab; Remission Induction; Severity of Illness Index; Steroids | 2008 |
Fulminant colitis.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Time Factors | 2008 |
In the case of nonresponse to steroids, what is the second level of treatment in ulcerative colitis?
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Humans; Infliximab; Risk Assessment; Steroids; Treatment Failure; Treatment Outcome; Tumor Necrosis Factor-alpha | 2008 |
Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction; Treatment Outcome | 2008 |
Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.
Topics: Antibodies, Monoclonal; Bacteremia; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Pancreatitis; Retrospective Studies; Salvage Therapy; Sepsis; Treatment Outcome | 2008 |
[Infliximab as rescue therapy after cyclosporin in an acute ulcerative colitis flare].
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged | 2008 |
Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy.
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Severity of Illness Index; Steroids | 2009 |
Long-term outcome after admission for acute severe ulcerative colitis in Oxford: the 1992-1993 cohort.
Topics: Adult; Azathioprine; Cohort Studies; Colectomy; Colitis, Ulcerative; Cost of Illness; Cyclosporine; England; Follow-Up Studies; Hospitalization; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Middle Aged; Predictive Value of Tests; Remission Induction; Retrospective Studies; Risk Factors; Severity of Illness Index; Steroids; Time Factors | 2009 |
Infliximab to treat severe ulcerative colitis.
Topics: Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Endoscopy; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Middle Aged; Treatment Outcome | 2009 |
Can we predict the response to cyclosporine?
Topics: Colitis, Ulcerative; Cyclosporine; Forecasting; Humans; Immunosuppressive Agents | 2009 |
Predictive factors of poor response to intravenous cyclosporine in steroid-refractory ulcerative colitis.
Topics: Adrenal Cortex Hormones; Adult; Colitis, Ulcerative; Cyclosporine; Female; Forecasting; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Treatment Failure | 2009 |
Role of endoscopic ultrasonography in predicting the response to cyclosporin A in ulcerative colitis refractory to steroids.
Topics: Adult; Colitis, Ulcerative; Colon; Colonoscopy; Cyclosporine; Endosonography; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Intestinal Mucosa; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Young Adult | 2009 |
Infliximab rescue therapy after cyclosporin failure in steroid-refractory ulcerative colitis.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Retrospective Studies; Treatment Failure; Young Adult | 2009 |
Role of medical rescue therapy in the management of acute severe ulcerative colitis: the surgical perspective.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Colonic Pouches; Cyclosporine; Digestive System Surgical Procedures; Drug Resistance; Gastrointestinal Agents; Humans; Infliximab; Patient Selection; Proctocolectomy, Restorative; Recurrence; Severity of Illness Index; Treatment Outcome | 2009 |
Peripheral regional aseptic neutrophilic lymphadenopathy associated with pyoderma gangrenosum.
Topics: Colitis, Ulcerative; Cyclosporine; Dermatologic Agents; Female; Glucocorticoids; Humans; Lymphatic Diseases; Middle Aged; Prednisolone; Pyoderma Gangrenosum; Sweet Syndrome; Treatment Outcome | 2009 |
Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis.
Topics: Acute Disease; Anti-Inflammatory Agents; Antibodies, Monoclonal; Bayes Theorem; Colectomy; Colitis, Ulcerative; Cost-Benefit Analysis; Cyclosporine; Decision Support Techniques; Gastrointestinal Agents; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Models, Economic; Models, Statistical; Monte Carlo Method; Quality-Adjusted Life Years; Treatment Outcome; United Kingdom | 2010 |
Treatment of fulminant ulcerative colitis with cyclosporine A.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome; Young Adult | 2009 |
Azathioprine, mucosal healing in ulcerative colitis, and the chemoprevention of colitic cancer: a clinical-practice-based forecast.
Topics: Adult; Apoptosis; Azathioprine; Cohort Studies; Colitis, Ulcerative; Colonic Neoplasms; Colonoscopy; Cyclosporine; Female; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Young Adult | 2010 |
[What is your diagnosis? Pyoderma gangrenosum].
Topics: Anti-Inflammatory Agents; Biopsy; Colitis, Ulcerative; Colon; Cyclosporine; Dermatologic Agents; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Prednisone; Pyoderma Gangrenosum | 2009 |
Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Colitis, Ulcerative; Cyclosporine; Elective Surgical Procedures; Female; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Postoperative Complications; Preoperative Care; Risk Factors; Steroids; Time Factors; Treatment Outcome; Young Adult | 2010 |
Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis.
Topics: Adolescent; Adult; Azathioprine; Colectomy; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Remission Induction; Retrospective Studies; Risk Factors; Secondary Prevention; Severity of Illness Index; Survival Rate; Treatment Outcome | 2010 |
Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patients.
Topics: Adolescent; Adult; Aged; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Young Adult | 2010 |
Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis.
Topics: Adolescent; Adult; Aged; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Intestinal Mucosa; Life Tables; Male; Middle Aged; Prognosis; Retrospective Studies; Severity of Illness Index; Time Factors; Young Adult | 2010 |
Pyodermatitis-pyostomatitis vegetans after subtotal colectomy for ulcerative colitis.
Topics: Azathioprine; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Diagnosis, Differential; Female; Humans; Mesalamine; Middle Aged; Prednisolone; Pyoderma; Recurrence; Stomatitis; Treatment Outcome | 2010 |
Cyclosporine is safe and effective in patients with severe ulcerative colitis.
Topics: Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Follow-Up Studies; Hospitalization; Humans; Immunosuppressive Agents; Length of Stay; Male; Mercaptopurine; Middle Aged; Severity of Illness Index; Time Factors; Treatment Outcome | 2011 |
Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Purines; Retrospective Studies; Severity of Illness Index; Treatment Failure; Treatment Outcome; Young Adult | 2010 |
Long-term efficacy and safety of cyclosporine as a rescue therapy in acute, steroid-refractory severe ulcerative colitis: switching to infliximab is more effective than treating with concomitant immunomodulators.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Length of Stay; Male; Mercaptopurine; Middle Aged; Salvage Therapy; Severity of Illness Index; Time Factors; Young Adult | 2011 |
Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis.
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Child; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Humans; Infections; Infliximab; Injections, Intravenous; Male; Middle Aged; Pulmonary Embolism; Retrospective Studies; Salvage Therapy; Steroids; Treatment Outcome; Young Adult | 2011 |
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Gastrointestinal Agents; Humans; Infliximab; Male; Middle Aged; Retrospective Studies; Risk; Treatment Outcome; Young Adult | 2012 |
The use of Cyclosporin A in acute steroid-refractory ulcerative colitis: long term outcomes.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Remission Induction; Steroids; Treatment Outcome; Young Adult | 2011 |
Cyclosporine in the management of severe ulcerative colitis while breast-feeding.
Topics: Adult; Breast Feeding; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Pregnancy; Pregnancy Complications; Remission Induction | 2011 |
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Cyclosporine; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Remission Induction; Severity of Illness Index; Sex Factors; Tacrolimus | 2011 |
Ulcerative colitis: Rescue immune suppression for severe colitis--worth the risk?
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Recurrence; Severity of Illness Index; Treatment Outcome | 2011 |
A case of ulcerative colitis accompanied with myelodysplastic syndrome successfully treated by cyclosporine.
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes | 2011 |
Nephrotic syndrome and Moya-moya syndrome in a patient with ulcerative colitis.
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclosporine; Fatal Outcome; Humans; Male; Mesalamine; Moyamoya Disease; Nephrotic Syndrome; Prednisone; Severity of Illness Index; Young Adult | 2012 |
Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin.
Topics: Adult; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Dermatologic Agents; Drug Resistance; Female; Humans; Immunosuppressive Agents; Infliximab; Prognosis; Pyoderma Gangrenosum | 2012 |
Avascular necrosis of the knees and ulcerative colitis.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Cholecalciferol; Colitis, Ulcerative; Cyclosporine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Knee Joint; Male; Mesalamine; Osteonecrosis; Pain; Platelet Aggregation Inhibitors; Radiography; Simvastatin; Vitamins | 2011 |
Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Chi-Square Distribution; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Infliximab; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Steroids; Substance-Related Disorders; Time Factors; Treatment Outcome; Young Adult | 2012 |
Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne.
Topics: Adolescent; Adult; Age Factors; Anal Canal; Analysis of Variance; Chi-Square Distribution; Colectomy; Colitis, Ulcerative; Constriction, Pathologic; Crohn Disease; Cyclosporine; Female; Hong Kong; Hospitalization; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Proportional Hazards Models; Sex Factors; Smoking; Steroids; Tumor Necrosis Factor Inhibitors; Victoria; Young Adult | 2012 |
Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements.
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Consensus; Cyclosporine; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Treatment Outcome | 2012 |
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Salvage Therapy; Severity of Illness Index; Spain; Treatment Outcome; Young Adult | 2012 |
Management of acute, severe ulcerative colitis.
Topics: Acute Disease; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Exsanguination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Neoplasms; Severity of Illness Index | 2012 |
Rescue therapy for steroid refractory acute severe ulcerative colitis: more choice, better outcomes?
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infliximab; Male | 2012 |
Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Cohort Studies; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2012 |
Surgery is a real alternative to rescue therapy in patients with steroid-refractory ulcerative colitis.
Topics: Anastomosis, Surgical; Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Steroids; Treatment Outcome | 2013 |
Predictors of proctocolectomy in children with ulcerative colitis.
Topics: Calcineurin Inhibitors; Child; Colitis, Ulcerative; Cyclosporine; Family; Female; Genetic Predisposition to Disease; Humans; Hypoalbuminemia; Immunosuppressive Agents; Incidence; Male; Proctocolectomy, Restorative; Risk Assessment; Serum Albumin; Tacrolimus; Time Factors; Weight Loss | 2012 |
Predictive factors of response to intravenous ciclosporin in severe ulcerative colitis: the development of a novel prediction formula.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Predictive Value of Tests; Severity of Illness Index; Treatment Outcome; Young Adult | 2012 |
Readministration of calcineurin inhibitors for ulcerative colitis.
Topics: Adolescent; Adult; Aged; Calcineurin Inhibitors; Child; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Tacrolimus; Treatment Outcome; Young Adult | 2012 |
Infliximab versus ciclosporin in severe ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Steroids | 2012 |
Ciclosporin no better than infliximab for acute refractory ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Chronic Disease; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab | 2012 |
Commentary: Predicting response to ciclosporin in acute severe ulcerative colitis.
Topics: Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male | 2012 |
Letter: should colectomy be the end-point to evaluate the effectiveness of drug therapies in severe ulcerative colitis?
Topics: Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male | 2013 |
Letter: should colectomy be the end-point to evaluate the effectiveness of drug therapies in severe ulcerative colitis? Authors' reply.
Topics: Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male | 2013 |
Ulcerative colitis: steroid-refractory ulcerative colitis-ciclosporin or infliximab?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Steroids | 2013 |
Extended abstract: Tacrolimus and cyclosporine in inflammatory bowel disease.
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Humans; Inflammatory Bowel Diseases; Infliximab; Polymorphism, Single Nucleotide; Tacrolimus; Treatment Failure | 2012 |
Development of ulcerative colitis despite long-term immunosuppression with cyclosporin and azathioprine in an Australian Aborigine.
Topics: Australia; Azathioprine; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Native Hawaiian or Other Pacific Islander | 2002 |
Cyclosporin therapy in severe ulcerative colitis: is it worth the effort?
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2002 |
Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis.
Topics: Administration, Oral; Adult; Azathioprine; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Prednisolone; Recurrence; Remission Induction; Treatment Outcome | 2002 |
Cyclosporin for refractory ulcerative colitis.
Topics: Azathioprine; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infusions, Intravenous; Mercaptopurine; Randomized Controlled Trials as Topic; Treatment Outcome | 2003 |
[Complicated ulcerative colitis].
Topics: Adult; Anti-Bacterial Agents; Biological Factors; Colitis, Ulcerative; Colonic Pouches; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Humans; Hydrocortisone; Immunosuppressive Agents; Male; Patient Care Team; Prednisolone; Pulse Therapy, Drug; Recurrence; Treatment Refusal | 2003 |
Infliximab salvage therapy after cyclosporine in an acute flare of chronic ulcerative colitis.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Chronic Disease; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Enzyme Inhibitors; Female; Gastrointestinal Agents; Humans; Infliximab; Treatment Failure | 2003 |
Inducing remission in inflammatory bowel disease.
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Remission Induction | 2003 |
Caution with the use of cyclosporin in pregnancy.
Topics: Colitis, Ulcerative; Cyclosporine; Female; Humans; Hypertension; Immunosuppressive Agents; Pregnancy; Pregnancy Complications, Cardiovascular | 2003 |
Successful treatment of steroid resistant ulcerative colitis associated with severe autoimmune hemolytic anemia with oral microemulsion cyclosporin--a brief case report.
Topics: Administration, Oral; Adult; Anemia, Hemolytic; Colitis, Ulcerative; Cyclosporine; Emulsions; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Treatment Outcome | 2003 |
Ulcerative colitis associated with aplastic anemia.
Topics: Adult; Anemia, Aplastic; Anti-Inflammatory Agents; Blood Transfusion; Bone Marrow Examination; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Male; Mesalamine; Prednisolone; Remission Induction; Treatment Outcome | 2003 |
Long-term results of low-dose intravenous ciclosporin for acute severe ulcerative colitis.
Topics: Acute Disease; Adolescent; Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Retreatment; Treatment Outcome | 2003 |
Antagonist: Early surgical intervention in ulcerative colitis.
Topics: Azathioprine; Chronic Disease; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Mercaptopurine; Patient Selection; Time Factors | 2004 |
Outcome of a conservative approach in severe ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Colectomy; Colitis, Ulcerative; Colonoscopy; Combined Modality Therapy; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Treatment Outcome | 2004 |
Long-term efficacy of oral microemulsion cyclosporin for refractory ulcerative colitis.
Topics: Administration, Oral; Azathioprine; Colitis, Ulcerative; Cyclosporine; Emulsions; Female; Humans; Immunosuppressive Agents; Male; Recurrence | 2004 |
Circulating levels of cyclosporin A in inflammatory bowel disease: relationships with lymphocyte inhibition and the age of patients.
Topics: Administration, Oral; Adult; Cell Division; Cellular Senescence; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Emulsions; Female; Humans; Inflammatory Bowel Diseases; Lymphocyte Activation; Lymphocytes; Male; Middle Aged | 2004 |
Open questions concerning cyclosporine therapy in ulcerative colitis.
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents | 2004 |
Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery.
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Patient Selection; Prognosis; Regression Analysis; Risk Assessment; Treatment Failure | 2004 |
Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis.
Topics: Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Probability; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Time Factors; Treatment Outcome | 2004 |
Cerebral sinus thrombosis associated with severe active ulcerative colitis.
Topics: Adult; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Follow-Up Studies; Heparin; Humans; Infusions, Intravenous; Leukapheresis; Magnetic Resonance Angiography; Male; Prednisolone; Radiographic Image Enhancement; Risk Assessment; Severity of Illness Index; Sigmoidoscopy; Sinus Thrombosis, Intracranial; Thrombolytic Therapy; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
[Chronic active ulcerative colitis. Efficacy of intravenous followed by oral cyclosporine combined with azathioprine].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Attitude of Health Personnel; Attitude to Health; Azathioprine; Chronic Disease; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Remission Induction; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome | 2004 |
Cyclosporin for severe ulcerative colitis attacks.
Topics: Administration, Oral; Adolescent; Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 2003 |
Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment.
Topics: Azathioprine; Blood Sedimentation; Body Temperature; C-Reactive Protein; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Humans; Logistic Models; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Pulse; Remission Induction; Treatment Outcome | 2004 |
Use of cyclosporin in pregnancy.
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Pregnancy; Pregnancy Complications | 2004 |
Benign intracranial hypertension during corticosteroid therapy for idiopathic ulcerative colitis: another indication for cyclosporine?
Topics: Adrenal Cortex Hormones; Adult; Colitis, Ulcerative; Cyclosporine; Female; Headache; Humans; Immunosuppressive Agents; Pseudotumor Cerebri; Vision Disorders | 2004 |
[Ulcerative colitis. Acute episode].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Mesalamine; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors | 2004 |
[Ulcerative colitis. Fulminant disease].
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Age Factors; Anti-Bacterial Agents; Case-Control Studies; Child; Colectomy; Colitis, Ulcerative; Colonoscopy; Controlled Clinical Trials as Topic; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Injections, Intravenous; Parenteral Nutrition; Prognosis; Prospective Studies; Remission Induction; Retrospective Studies; Time Factors | 2004 |
[Immunosuppressive therapy for inflammatory bowel disease: consensus by the Austrian working group on IBD].
Topics: Administration, Oral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Injections, Intramuscular; Male; Mercaptopurine; Methotrexate; Placebos; Pregnancy; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Safety; Time Factors | 2004 |
Recurrent infusion phlebitis induced by cyclosporine.
Topics: Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclosporine; Humans; Hydrocortisone; Immunosuppressive Agents; Infusions, Intravenous; Male; Phlebitis; Recurrence | 2004 |
Effect of cyclosporin A on cell adhesion molecules and leukocyte-endothelial cell interactions in experimental colitis.
Topics: Animals; Cell Adhesion Molecules; Cell Communication; Colitis, Ulcerative; Cyclosporine; Disease Models, Animal; Endothelial Cells; Immunoglobulins; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Leukocytes; Male; Mice; Mice, Inbred Strains; Mucoproteins; Vascular Cell Adhesion Molecule-1 | 2004 |
Ciclosporin use in acute ulcerative colitis: a long-term experience.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrocortisone; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome | 2005 |
Development of ulcerative colitis after heart transplantation during immunosuppressive therapy.
Topics: Biopsy; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Disease Progression; Heart Failure; Heart Transplantation; Humans; Ileostomy; Immunosuppressive Agents; Intestinal Mucosa; Long-Term Care; Male; Middle Aged; Polymerase Chain Reaction; Postoperative Complications; Predictive Value of Tests; Prednisolone; Recurrence; Reoperation | 2005 |
Long-term outcome of intractable ulcerating enterocolitis of infancy.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Chronic Disease; Colectomy; Colitis, Ulcerative; Cyclosporine; Enterocolitis; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Humans; Immunoglobulins; Immunosuppressive Agents; Infant; Infant, Newborn; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Steroids; Thalidomide; Time Factors; Treatment Outcome | 2005 |
A case of cyclosporine-induced dural sinus thrombosis.
Topics: Colitis, Ulcerative; Cyclosporine; Female; Humans; Middle Aged; Sinus Thrombosis, Intracranial; Thrombophilia | 2005 |
Intravenous cyclosporine for the treatment of severe steroid refractory ulcerative colitis: what is the cost?
Topics: Adult; Analysis of Variance; Anastomosis, Surgical; Chi-Square Distribution; Colectomy; Colitis, Ulcerative; Colonic Pouches; Cyclosporine; Female; Hospital Costs; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Retrospective Studies; Steroids; Treatment Failure | 2005 |
Infliximab or cyclosporine for severe ulcerative colitis.
Topics: Antibodies, Monoclonal; Clinical Trials as Topic; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Infliximab | 2005 |
[Intestinal tissue kallikrein-kinin system in patients with ulcerative colitis during treatment with cyclosporine A].
Topics: Caco-2 Cells; Colitis, Ulcerative; Colon, Sigmoid; Cyclosporine; Female; Gene Expression Regulation; Humans; In Vitro Techniques; Kallikrein-Kinin System; Male; Polymerase Chain Reaction; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Sigmoidoscopy; Time Factors | 2005 |
Disseminated intravascular coagulation associated with systemic cytomegalovirus infection during cyclosporine therapy for ulcerative colitis: report of a case.
Topics: Adult; Antiviral Agents; Colitis, Ulcerative; Cyclosporine; Cytomegalovirus Infections; Disseminated Intravascular Coagulation; Follow-Up Studies; Ganciclovir; Humans; Immunosuppressive Agents; Male | 2006 |
Pyoderma gangrenosum--case report.
Topics: Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclosporine; Diagnosis, Differential; Facial Dermatoses; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Neck; Prednisolone; Pyoderma Gangrenosum | 2007 |
[Cyclosporine in ulcerative colitis flares].
Topics: Administration, Oral; Adrenal Cortex Hormones; Azathioprine; Colitis, Ulcerative; Colonoscopy; Controlled Clinical Trials as Topic; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Tumor Necrosis Factor-alpha | 2005 |
Infliximab or cyclosporine for severe ulcerative colitis.
Topics: Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Eligibility Determination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Reproducibility of Results; Research Design | 2006 |
Is oral ciclosporin necessary to switch from i.v. to thiopurines?
Topics: Administration, Oral; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Injections, Intravenous | 2006 |
Rectal malignant lymphoma complicating ulcerative colitis treated with long-term cyclosporine A.
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Rectal Neoplasms | 2006 |
Strongyloides stercoralis infestation in a patient with severe ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclosporine; Early Diagnosis; Humans; Hydrocortisone; Immunosuppressive Agents; Male; Prednisolone; Strongyloides stercoralis; Strongyloidiasis; Tropical Medicine | 2006 |
Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis.
Topics: Adolescent; Adult; Aged; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Remission Induction; Survival Analysis | 2006 |
Do patient preferences influence decisions on treatment for patients with steroid-refractory ulcerative colitis?
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Colonic Pouches; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Markov Chains; Middle Aged; Patient Satisfaction; Proctocolectomy, Restorative; Treatment Outcome | 2006 |
[Fatal giant-cell myocarditis complicated with ulcerative colitis].
Topics: Adult; Autoimmunity; Cardiopulmonary Bypass; Colitis, Ulcerative; Cyclosporine; Echocardiography; Fatal Outcome; Humans; Immunosuppressive Agents; Intra-Aortic Balloon Pumping; Male; Myocarditis; Myocardium | 2006 |
Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel disease.
Topics: Adult; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Colitis, Ulcerative; Colonic Pouches; Cyclosporine; Glucocorticoids; Humans; Ileum; Immunosuppressive Agents; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mercaptopurine; Prednisone | 2006 |
Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy.
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth | 2006 |
Role of cyclosporin in preventing or delaying colectomy in children with severe ulcerative colitis.
Topics: Adolescent; Adult; Child; Child, Preschool; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infant; Male; Remission Induction; Treatment Outcome | 2007 |
[Efficacy of combination of intravenous cyclosporin A and steroid therapy versus prolonged intravenous steroid therapy alone in patients with severe ulcerative colitis refractory to initial intravenous steroid therapy].
Topics: Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Injections, Intravenous; Male; Middle Aged; Steroids; Treatment Outcome | 2006 |
[Treatment of steroid refractory ulcerative colitis].
Topics: Colitis, Ulcerative; Cyclosporine; Drug Tolerance; Humans; Hydrocortisone; Injections, Intravenous; Methylprednisolone | 2006 |
Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.
Topics: Adolescent; Adult; Aged; Antibodies, Anti-Idiotypic; Antigens, Viral; Biopsy; Colitis, Ulcerative; Colon; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Virus Activation | 2007 |
Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Colitis, Ulcerative; Cyclosporine; Drug Resistance, Multiple; Female; Gene Frequency; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Polymorphism, Single Nucleotide | 2007 |
Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery.
Topics: Adolescent; Calcineurin Inhibitors; Child; Child, Preschool; Colitis, Ulcerative; Colonic Pouches; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Proctocolectomy, Restorative; Retrospective Studies; Tacrolimus; Treatment Outcome | 2007 |
[Case of severe ulcerative colitis successfully treated with intravenous cyclosporine without high dose corticosteroid].
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Mercaptopurine; Prednisolone; Treatment Outcome | 2007 |
Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan.
Topics: Adolescent; Adult; Antiviral Agents; Colitis, Ulcerative; Cyclosporine; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Immunosuppressive Agents; Injections, Intravenous; Japan; Male; Middle Aged; Severity of Illness Index | 2007 |
Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study.
Topics: Administration, Oral; Adult; Chi-Square Distribution; Cohort Studies; Colectomy; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Prednisolone; Probability; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Time Factors; Treatment Outcome | 2007 |
Cyclosporin A treatment of steroid-refractory ulcerative colitis during pregnancy: report of two cases.
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Pregnancy; Pregnancy Complications | 2007 |
Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Child; Colectomy; Colitis, Ulcerative; Colonic Pouches; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Morbidity; Postoperative Complications; Treatment Failure | 2007 |
Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Risk Factors; Treatment Outcome | 2008 |
Steroid-refractory ulcerative colitis: predictive factors of response to cyclosporine and validation in an independent cohort.
Topics: Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Prednisolone; Prevalence; Prospective Studies; Spain | 2008 |
Refractory ulcerative colitis and iatrogenic colorectal Kaposi's sarcoma.
Topics: Adult; Colectomy; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Cyclosporine; Glucocorticoids; Humans; Iatrogenic Disease; Immunosuppression Therapy; Immunosuppressive Agents; Male; Prednisone; Sarcoma, Kaposi | 2009 |
Severe systemic cytomegalovirus infections in patients with steroid-refractory ulcerative colitis treated by an oral microemulsion form of cyclosporine: report of two cases.
Topics: Administration, Oral; Adult; Colitis, Ulcerative; Cyclosporine; Cytomegalovirus Infections; Emulsions; Female; Humans; Immunosuppressive Agents; Severity of Illness Index | 2008 |
Leukocytapheresis in a girl with severe ulcerative colitis refractory to corticosteroids, infliximab, and cyclosporine A.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Child; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Humans; Infliximab; Leukapheresis; Remission Induction; Severity of Illness Index; Treatment Outcome | 2008 |
Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.
Topics: Adult; Apgar Score; Azathioprine; Case-Control Studies; Cesarean Section; Colectomy; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydrocortisone; Immunosuppressive Agents; Infant, Newborn; Infusions, Intravenous; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Recurrence | 2008 |
[Effectiveness of maintenance azathioprine therapy without oral cyclosporine after severe attacks of ulcerative colitis refractory to endovenous steroids].
Topics: Adolescent; Adult; Aged; Azathioprine; Colitis, Ulcerative; Cyclosporine; Female; Humans; Hydrocortisone; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Severity of Illness Index; Treatment Failure | 2008 |
Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Viral; Case-Control Studies; Colitis, Ulcerative; Comorbidity; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Diagnosis, Differential; Drug Resistance; Female; Humans; Immunohistochemistry; Male; Middle Aged; Prevalence; Prospective Studies; Severity of Illness Index; Steroids; Young Adult | 2008 |
[Case of ulcerative colitis refractory to intravenous cyclosporine therapy successfully treated with infliximab].
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Drug Resistance; Female; Gastrointestinal Agents; Humans; Infliximab; Infusions, Intravenous; Prednisolone; Treatment Outcome | 2008 |
Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin.
Topics: Adolescent; Adult; Child; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Drug Resistance; Female; Humans; Ileostomy; Immunosuppressive Agents; Intestinal Obstruction; Intestine, Small; Length of Stay; Male; Middle Aged; Rectum; Retrospective Studies; Safety; Surgical Wound Dehiscence; Surgical Wound Infection; Thrombophlebitis | 1995 |
[Cyclosporin--a solution or dead end in treatment of chronic inflammatory bowel diseases?].
Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Enema; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 1995 |
Cyclosporine therapy for inflammatory bowel disease: definitive answers and remaining questions.
Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Inflammatory Bowel Diseases | 1995 |
Efficacy of intravenous cyclosporine for steroid refractory attacks of ulcerative colitis.
Topics: Adolescent; Adult; Aged; Colitis, Ulcerative; Cyclosporine; Drug Combinations; Female; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Treatment Failure; Treatment Outcome | 1995 |
Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients.
Topics: Azathioprine; Cholangitis, Sclerosing; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Transplantation; Male; Middle Aged; Muromonab-CD3; Retrospective Studies; Steroids; Tacrolimus | 1993 |
Adult-onset cyclic neutropenia responsive to cyclosporine therapy in a patient with ankylosing spondylitis.
Topics: Blood Cell Count; Colitis, Ulcerative; Cyclosporine; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Periodicity; Spondylitis, Ankylosing | 1993 |
Cyclosporine treatment of severe ulcerative colitis during pregnancy.
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Female; Humans; Pregnancy; Pregnancy Complications; Severity of Illness Index | 1995 |
Cyclosporine for the treatment of fulminant ulcerative colitis in children. Immediate response, long-term results, and impact on surgery.
Topics: Abdominal Pain; Administration, Oral; Adolescent; Adult; Child; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Diarrhea; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous; Male; Methylprednisolone; Parenteral Nutrition; Patient Discharge; Proctocolectomy, Restorative; Recurrence; Remission Induction | 1995 |
Cyclosporine as an alternative to surgery in children with inflammatory bowel disease.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Child; Colitis, Ulcerative; Cyclosporine; Humans; Male; Prednisone; Treatment Failure | 1994 |
Cyclosporine and 6-mercaptopurine in pediatric inflammatory bowel disease.
Topics: Child; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Methylprednisolone; Parenteral Nutrition, Total; Sulfasalazine | 1994 |
Mucosal interleukin-6 secretion in ulcerative colitis. Effects of anti-inflammatory drugs and T-cell stimulation.
Topics: Anti-Inflammatory Agents; Biopsy; Cells, Cultured; Colitis, Ulcerative; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Humans; In Vitro Techniques; Interleukin-6; Intestinal Mucosa; Lymphocyte Activation; T-Lymphocytes | 1994 |
Cyclosporine in severe ulcerative colitis.
Topics: Bone Marrow Transplantation; Colitis, Ulcerative; Cyclosporine; Humans; Kidney Transplantation; Seizures | 1995 |
[Severe active ulcerative colitis responding to cyclosporin].
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Humans; Male | 1994 |
Cyclosporine therapy for inflammatory bowel disease.
Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans | 1994 |
Cyclosporin for the treatment of severe ulcerative colitis.
Topics: Adult; Aged; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Recurrence | 1994 |
Acute reversible central nervous system toxicity associated with low-dose oral cyclosporine therapy.
Topics: Adult; Brain Diseases; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Facial Dermatoses; Female; Humans; Pyoderma; Seizures | 1993 |
Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin.
Topics: Acute Disease; Animals; Chronic Disease; Colitis, Ulcerative; Colon; Cyclosporine; Dextran Sulfate; Disease Models, Animal; Enema; Female; Mice | 1993 |
Continuously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids.
Topics: Acute Disease; Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Emergencies; Female; Humans; Hydrocortisone; Infusions, Intravenous; Male; Middle Aged; Time Factors | 1993 |
Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
Topics: Adolescent; Adult; Attitude of Health Personnel; Azathioprine; Child; Colitis; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Gastroenterology; Health Surveys; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Methotrexate; Pediatrics; Remission Induction; Retrospective Studies; Societies, Medical; Surveys and Questionnaires | 1993 |
Can cyclosporin prevent proctocolectomy in severe steroid-refractory ulcerative colitis? Lessons from a case report.
Topics: Adult; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Female; Humans; Proctocolectomy, Restorative; Remission Induction | 1993 |
Ulcerative colitis and total alopecia in a mother and her son.
Topics: Adult; Alleles; Alopecia; Child; Colitis, Ulcerative; Cyclosporine; Female; Histocompatibility Testing; HLA Antigens; Humans; Male; Pedigree | 1993 |
Cyclosporine and other immunosuppressive agents: current and future role in the treatment of inflammatory bowel disease.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Intestinal Neoplasms; Lymphoma; Mercaptopurine; Risk Factors | 1993 |
Predictors and the rate of medical treatment failure in ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Cyclosporine; Discriminant Analysis; Female; Humans; Male; Mesalamine; Methotrexate; Prognosis; Risk Factors; Steroids; Treatment Failure | 1993 |
Cyclosporin use in the precolectomy chronic ulcerative colitis patient: a community experience and its relationship to prospective and controlled clinical trials. Pacific Northwest Gastroenterology Society.
Topics: Adolescent; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Colectomy; Colitis, Ulcerative; Cyclosporine; Data Collection; Female; Gastroenterology; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Preoperative Care; Prospective Studies; Treatment Outcome; Washington | 1995 |
Hepatotoxicity of intravenous cyclosporin A in patients with acute ulcerative colitis on total parenteral nutrition.
Topics: Acute Disease; Adolescent; Adult; Cholangitis; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Parenteral Nutrition, Total; Retrospective Studies; Transaminases | 1995 |
[Cytomegalovirus infection in hemorrhagic rectocolitis treated with cyclosporine].
Topics: Colitis, Ulcerative; Cyclosporine; Cytomegalovirus Infections; Humans; Immunosuppressive Agents; Male; Middle Aged | 1996 |
[Natural history of treated hemorrhagic rectocolitis].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Antirheumatic Agents; Colectomy; Colitis, Ulcerative; Colorectal Neoplasms; Combined Modality Therapy; Cyclosporine; Humans; Recurrence | 1996 |
[Polyarticular pain syndrome during treatment with cyclosporine for severe acute colitis].
Topics: Acute Disease; Adult; Antirheumatic Agents; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intravenous; Osteoarthritis; Prednisone | 1996 |
Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis.
Topics: Adult; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Remission Induction; Steroids; Time Factors | 1996 |
Predicting outcome in severe ulcerative colitis.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Colectomy; Colitis, Ulcerative; Cyclosporine; Defecation; Feces; Female; Hospitalization; Humans; Immunosuppressive Agents; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Radiography | 1996 |
[Hemorrhagic rectocolitis in a cardiac transplant recipient under long-term cyclosporine].
Topics: Colitis, Ulcerative; Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Time Factors | 1996 |
Cyclosporin treatment for ulcerative colitis complicated by fatal Pneumocystis carinii pneumonia.
Topics: Colitis, Ulcerative; Cyclosporine; Fatal Outcome; Humans; Immunocompromised Host; Male; Middle Aged; Pneumonia, Pneumocystis | 1997 |
[Cyclosporin for severe ulcerative colitis].
Topics: Administration, Oral; Colitis, Ulcerative; Cyclosporine; Humans; Infusions, Intravenous; Treatment Outcome | 1997 |
Pneumocystis carinii pneumonia postrestorative proctocolectomy for ulcerative colitis: a role for perioperative prophylaxis in the cyclosporine era? Report of a case and review of the literature.
Topics: Adult; Antibiotic Prophylaxis; Colitis, Ulcerative; Cyclosporine; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Opportunistic Infections; Pneumonia, Pneumocystis; Postoperative Complications; Proctocolectomy, Restorative | 1997 |
Onset of ulcerative colitis during immunosuppressive therapy for liver transplantation.
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Prednisone | 1997 |
Immunomodulator therapy of inflammatory bowel disease.
Topics: Antimetabolites, Antineoplastic; Azathioprine; Blood Component Removal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Cytokines; Folic Acid Antagonists; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate | 1997 |
[Treatment with cyclosporine of severe colitis in hemorrhagic rectocolitis. Apropos of 7 cases].
Topics: Acute Disease; Adult; Colitis; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies; Time Factors | 1997 |
Severe knee pain as the single symptom of CMV infection in acute ulcerative colitis treated with cyclosporine.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Knee; Male; Methylprednisolone; Pain | 1998 |
Oral cyclosporin in refractory inflammatory bowel disease.
Topics: Administration, Oral; Adolescent; Adult; Aged; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Retrospective Studies; Treatment Outcome | 1998 |
Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis.
Topics: Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Prednisolone; Prospective Studies; Recurrence; Treatment Failure; Treatment Outcome | 1998 |
Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal?
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclosporine; Female; Humans; Hydrocortisone; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 1998 |
[Refractory severe ulcerative colitis. Experience with cyclosporine].
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Male; Middle Aged; Severity of Illness Index | 1998 |
Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and cyclosporine.
Topics: Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Facial Dermatoses; Female; Humans; Immunosuppressive Agents; Methylprednisolone; Pregnancy; Pregnancy Complications; Pyoderma Gangrenosum | 1998 |
Neoral may be as effective as intravenous cyclosporine in the treatment of steroid-resistant ulcerative colitis.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Humans; Hydrocortisone; Immunosuppressive Agents; Injections, Intravenous; Male; Remission Induction | 1998 |
Addition of low-dose oral cyclosporine in severe ulcerative colitis--pharmacokinetics and clinical outcome report of twelve cases.
Topics: Administration, Oral; Adolescent; Adult; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Treatment Outcome | 1998 |
Steroid-refractory severe ulcerative colitis responding to cyclosporine and long-term follow-up.
Topics: Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Steroids | 1998 |
Cyclosporine for inflammatory bowel disease--an epoch-making therapy for corticosteroid-resistant or dependent patients?
Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Humans; Immunosuppressive Agents; Steroids; Substance-Related Disorders | 1998 |
Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Pilot Projects; Prospective Studies; Remission Induction; Steroids; Tacrolimus; Time Factors; Treatment Failure | 1998 |
[Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
Topics: Administration, Oral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infusions, Intravenous; Prednisone; Recurrence; Treatment Outcome | 1998 |
Cigarette smoking should not be prescribed for the treatment of ulcerative colitis.
Topics: Adrenal Cortex Hormones; Clinical Trials as Topic; Colitis, Ulcerative; Cyclosporine; Humans; Nicotine; Recurrence; Smoking; Sulfasalazine | 1998 |
Cytomegalovirus infection in patients with inflammatory bowel disease.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antiviral Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone | 1999 |
Immunosuppressive therapy for ulcerative colitis: results of a nation-wide survey among consultant physician members of the British Society of Gastroenterology.
Topics: Azathioprine; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Referral and Consultation | 1999 |
Intravenous cyclosporin in ulcerative colitis: a five-year experience.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Longitudinal Studies; Male; Mercaptopurine; Middle Aged; Retreatment; Steroids; Treatment Outcome | 1999 |
Cyclosporine therapy in inflammatory bowel disease: short-term and long-term results.
Topics: Administration, Oral; Adolescent; Adult; Colectomy; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Recurrence; Time Factors; Treatment Outcome | 1999 |
Oral microemulsion cyclosporin to reduce steroids rapidly in chronic active ulcerative colitis.
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Emulsions; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Retrospective Studies; Treatment Outcome | 1999 |
[Intravenous cyclosporine therapy for ulcerative colitis refractory to steroid therapy].
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Prednisolone | 1999 |
Pyoderma gangrenosum after augmentation mammoplasty.
Topics: Adult; Breast Implantation; Colitis, Ulcerative; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Pyoderma Gangrenosum; Reoperation; Surgical Wound Infection | 1999 |
Overlapping syndrome of autoimmune hepatitis and primary sclerosing cholangitis associated with pyoderma gangrenosum and ulcerative colitis.
Topics: Adolescent; Cholangitis, Sclerosing; Colitis, Ulcerative; Cyclosporine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Pyoderma Gangrenosum | 1999 |
Cyclosporin for steroid-refractory ulcerative colitis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infusions, Intravenous; Treatment Outcome | 2000 |
Severe steroid-unresponsive ulcerative colitis: outcomes of restorative proctocolectomy in patients undergoing cyclosporin treatment.
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Female; Follow-Up Studies; Hospital Mortality; Humans; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Proctocolectomy, Restorative; Reoperation; Risk Factors; Survival Analysis | 2000 |
Recurrent septicemia with lethal outcome during and after cyclosporine therapy in severe ulcerative colitis.
Topics: Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Fatal Outcome; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Recurrence; Sepsis; Staphylococcal Infections | 2000 |
Cyclosporine has a direct effect on the differentiation of a mucin-secreting cell line.
Topics: Calmodulin; Cell Differentiation; Cell Division; Cell Line; Colitis, Ulcerative; Cyclosporine; Cyclosporins; Glycoproteins; Goblet Cells; Humans; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Mucins; Prolactin; Prostaglandin-Endoperoxide Synthases | 2000 |
Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Mesalamine; Middle Aged; Prognosis; Retrospective Studies; Steroids | 2000 |
Cyclosporin for severe ulcerative colitis.
Topics: Adolescent; Adult; Child; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2000 |
Pathophysiology and new therapeutic approaches in inflammatory bowel disease.
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents | 2000 |
Aspergillus fumigatus pneumonia during cyclosporine treatment for ulcerative colitis.
Topics: Aspergillosis; Aspergillus fumigatus; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Lung Diseases, Fungal; Male; Middle Aged | 2000 |
Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease.
Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Recurrence; Treatment Outcome | 2000 |
[Therapy of chronic inflammatory intestinal disease].
Topics: Acute Disease; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Budesonide; Chronic Disease; Colectomy; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Combinations; Gastrointestinal Agents; Glucosamine; Humans; Immunosuppressive Agents; Infliximab; Sulfasalazine | 2000 |
Beneficial intervention of experimental colitis by passive cigarette smoking through the modulation of cytokines in rats.
Topics: Animals; Benzenesulfonates; Colitis, Ulcerative; Cyclosporine; Cytokines; Humans; Male; Pentoxifylline; Rats; Rats, Sprague-Dawley; Tobacco Smoke Pollution; Tumor Necrosis Factor-alpha | 2001 |
Intravenous cyclosporine in severe ulcerative colitis: ready to stand alone?
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Kidney | 2001 |
In-vitro cyclosporin sensitivity of proliferating lymphocytes is predictive of in-vivo therapeutic response in ulcerative colitis.
Topics: Adult; Cell Culture Techniques; Cell Division; Colitis, Ulcerative; Cyclosporine; Drug Evaluation, Preclinical; Humans; Immunosuppressive Agents; Lymphocytes; Predictive Value of Tests; Prognosis; Treatment Outcome | 2001 |
Oral microemulsion cyclosporine in the treatment of steroid-refractory attacks of ulcerative and indeterminate colitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Colitis; Colitis, Ulcerative; Cyclosporine; Emulsions; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Time Factors | 2001 |
Nocardia asteroides lung abscess in acute ulcerative colitis treated with cyclosporine.
Topics: Acute Disease; Aged; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Lung Abscess; Male; Nocardia asteroides; Nocardia Infections; Opportunistic Infections; Radiography | 2001 |
Pharmacokinetics of cyclosporin microemulsion in patients with inflammatory bowel disease.
Topics: Adolescent; Adult; Analysis of Variance; Area Under Curve; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Dose-Response Relationship, Drug; Emulsions; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Middle Aged | 2001 |
Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis.
Topics: Adult; Aged; Azathioprine; Case-Control Studies; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2001 |
[Cyclosporine treatment of patients with active ulcerative colitis refractory to high-dose glucocorticoid].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Injections, Intravenous; Middle Aged; Retrospective Studies; Treatment Outcome | 2001 |
Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Humans; Ileostomy; Immunosuppressive Agents; Infusions, Intravenous; Intraoperative Complications; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Steroids | 2001 |
Cyclosporine, or cyclosporine not, for severe ulcerative colitis.
Topics: Clinical Trials as Topic; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Severity of Illness Index | 2001 |
Effects of cyclosporine in steroid-refractory severe acute ulcerative colitis.
Topics: Acute Disease; Adult; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Steroids | 2002 |
Severe neurological complications of ulcerative colitis.
Topics: Adult; Azathioprine; Central Nervous System Diseases; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone | 2002 |
Comments on experimental use of intravenous cyclosporine (CsA) alone to treat severe ulcerative colitis.
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Injections, Intravenous; Severity of Illness Index | 2001 |
[Ulcerative colitis associated with relapsing polychondritis].
Topics: Adult; Autoimmunity; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Humans; Polychondritis, Relapsing; Prednisolone; Treatment Outcome | 2001 |
Suppressive effects of cyclosporine A on neutrophils and T cells may be related to therapeutic benefits in patients with steroid-resistant ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents; Child; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; In Vitro Techniques; Intestinal Mucosa; Male; Mesalamine; Neutrophils; Prednisolone; Suppressor Factors, Immunologic; T-Lymphocytes | 2002 |
Fulminant colitis: the case for operative treatment.
Topics: Acute Disease; Colitis, Ulcerative; Cyclosporine; Humans; Hydrocortisone; Proctocolectomy, Restorative; Severity of Illness Index | 2002 |
Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis.
Topics: Adult; Calcitriol; Cell Physiological Phenomena; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; In Vitro Techniques; Male; Middle Aged; T-Lymphocytes; Vitamin D | 2002 |
Longer term outcome of steroid refractory ulcerative colitis treated with intravenous cyclosporine without subsequent oral cyclosporine maintenance therapy.
Topics: Administration, Oral; Adult; Aged; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Remission Induction | 2002 |
Development of ulcerative colitis under the immunosuppressive effect of cyclosporine.
Topics: Colitis, Ulcerative; Contraindications; Cyclosporine; Humans; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Postoperative Complications; Sulfasalazine | 1992 |
Measurement of colonic tissue cyclosporine concentration in children with severe ulcerative colitis.
Topics: Administration, Oral; Adolescent; Aminosalicylic Acids; Child; Colitis, Ulcerative; Colon; Cyclosporine; Female; Humans; Mesalamine; Methylprednisolone; Sulfasalazine | 1992 |
Pneumocystis carinii pneumonia during cyclosporine therapy for ulcerative colitis.
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Humans; Male; Pneumonia, Pneumocystis | 1992 |
Cyclosporine treatment of severe ulcerative colitis in children.
Topics: Adolescent; Child; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Prednisone; Treatment Outcome | 1991 |